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Summary 
 
The widespread emergence of pathogens resistant to the majority of available antibiotics 
makes it necessary to find new ways to combat the corresponding microorganisms. Adaptive 
immunity is specific to vertebrates but the mechanisms of innate immunity are ancient and 
highly conserved during evolution. Therefore it is reasonable to use model organisms to study 
the molecular mechanisms of host defence and the corresponding mechanisms of 
pathogenicity.  
Microbacterium nematophilum adheres to the rectum of a Caenorhabditis elegans animal 
inducing a localized non-lethal response that causes swelling of the underlying hypodermal 
tissue. The aim of this thesis was to gain a first insight into the molecular mechanisms 
underlying the resistance of srf-3 animals to the bacterial pathogens Microbacterium 
nematophilum and Yersinia pestis/pseudotuberculosis.  M. nematophilum adheres to the 
cuticle of wild type animals but fails to adhere to the surface of srf-3 worms. This is a novel 
type of resistance because pathogens like P. aeruginosa or Salmonella typhimurium do not 
adhere to the cuticle but kill C. elegans by colonization and accumulation in the intestine. 
Molecular cloning of srf-3 showed that this gene codes for a type III transmembrane protein 
similar to the family of UDP-galactose transporters. Expression analysis revealed that SRF-3 
is expressed in a set of active secretory cells consistent with a function of this gene in cuticle 
or surface modification.  A functional characterization of SRF-3 revealed that this protein can 
function as a nucleotide sugar transporter. The protein showed multisubstrate specificity 
capable of translocating UDP-galactose and UDP-N-acetylglucosamine in vitro as judged by 
transport assays done with Golgi/ER enriched vesicles, as well as in vivo, as shown by the 
phenotypic correction of mutants defective in UDP-galactose or UDP-N-acetylglucosamine 
transport.  
The data presented in this thesis emphasize the importance of glycosylation in regulating the 
surface antigenicity of C. elegans. This can help to understand the process of pathogen 
adherence, the first step in the establishment of an infection, as well as how parasitic 
nematodes modulate the surface in order to escape the host response.      
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Figure 1: Picture of the swollen 
nymph glands in the neck of a 
bubonic plague patient (http:// 
groups.msn.com/CellNEWS/plag
ue.msnw)
Introduction 
 
Contagious diseases always represented a major threat to mankind and had a significant 
impact in human history. A disastrous example is the influenza pandemic 1918-1919 (Spanish 
influenza) killing approximately 40 million people worldwide (Crosby, 1989) Another 
prominent example is plague which caused one of the major biological-environmental events 
in European history in the mid-14th century (Black Death) 
killing approximately 17 to 28 million people and thereby 30 
to 40% of the European population (Gottfried, 1983) (Figure 
1 shows an example of a plague infected individual). 
Whereas the European of the middle age facing the Black 
Death was overwhelmed by a sense of inevitable doom, the 
common person of the late 20th century does not come into 
contact with plague or other dangerous infectious diseases. 
But it was not until the late 19th century that due to the 
pioneering works of Louis Pasteur (1822-1895) and Robert 
Koch (1843-1910), transferable diseases are viewed as a microbiological problem. Today we 
know that various species of worms, protozoa, fungi or viruses can cause diseases. Therefore 
pathogens are mircoorganisms and smaller biological active entities that have the ability to 
infect higher organisms and cause disease.  
The development of a vaccine against Smallpox by Edward Jenner in 1798, against Rabies by 
Louis Pasteur in 1885, and the discovery of penicillin (Fleming, 1929) represent the 
breakthroughs in the combat against infectious diseases and led to a worldwide retreat of this 
threat. In the 1960s it seemed that many infectious diseases had been nearly eliminated. 
However, an increasing number of antibiotic-resistant pathogens have been reported since 
then and in 1997 a Staphylococcus aureus strain, the major cause of hospital-acquired 
infections, resistant to all antibiotics currently available was isolated from a patient sample 
(Hiramatsu et al., 1997). Therefore, the development of new therapeutic and prophylactic 
approaches in the treatment of infectious diseases has become a major challenge for the 
future. Currently two strategies are being pursued. One approach is to develop modified 
versions of currently available antibiotics to inhibit the classic targets like cell wall synthesis, 
nucleotide/protein synthesis, DNA replication or the cytoplasmic membrane (Walsh, 2000). A 
second and new approach is to identify and fight bacterial factors that are essential to the 
infection process. The idea is that, if important virulence factors can be neutralized, the 
infection can be blocked at their earliest step which is the establishment of the corresponding 
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pathogens within the host (Ziebuhr, 2002).  Molecular characterization of virulence factors 
showed that genes affecting virulence of pathogens can be classified in specific and non-
specific factors. Specific factors like capsules, adhesins, toxins or invasions factors play an 
active role in the outbreak of the disease, e.g. breaking through the host defences, whereas 
non-specific factors like iron-complexing systems generate the biological prerequisite for the 
onset of disease (Finlay and Falkow, 1997). The fact that certain pathogens are capable of 
infecting a broad range of organisms points to the existence of universal virulence factors 
necessary for full pathogenicity in every host. On the other hand, the remarkable host 
specificity shown by some pathogens, e.g. the human specific gastric pathogen Heliobacter 
pylori, the causative agent in chronic active gastritis and peptic ulcer disease (Dubois, 1995), 
strongly suggests a bidirectional interaction between pathogen and host. Therefore, to 
understand diseases one has to study both sides of the bacteria-host interaction.  
Complex multicellular organisms have developed sophisticated mechanisms to protect 
themselves against invading microorganisms. Whereas the vertebrate immune system can 
respond to infection with an innate or a potent adaptive defence, most other multicellular 
organisms solely rely on the phylogenetically conserved innate immunity. The marked 
conservation of the innate immune defence system makes it possible to study and understand 
the mechanisms of this immune response in invertebrate organisms (Hoffmann et al., 1999). 
For example, the involvement of the Toll pathway, one of the major defence signalling 
cascades in innate immunity, was first described in Drosophila melanogaster (Lemaitre et al., 
1996).  
 
Caenorhabditis elegans as a model in innate immunity 
Originally, the soil nematode C. elegans (see Figure 2) was chosen by Sydney Brenner for 
studying fundamental aspects of developmental and neuronal biology (Brenner, 1973). It 
offers great potential for genetic analysis because of its three day life cycle, small size, 
combination of self and cross fertilization and the fact that it can be easily cultivated in the 
laboratory. Due to its transparency the anatomy of the animals can be analysed by light 
microscopy leading to the description of the entire cell lineage. The full genome sequence has 
been determined in 1998 and a broad set of tools for genetic and biochemical manipulations 
has been developed.  
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Figure 3: Confocal images showing bacterial 
colonization of the C. elegans intestine. (a,b): E. coli
DH5a–GFP, (c,d): S. typhimurium SL1344-GFP, (e,f): 
P. aeruginosa PA14–GFP. Scale bar represents 50 
µm. Intestinal margins are indicated with arrows.
Figure was taken from Aballay et al., (2000) 
 
Figure 2: Photographs showing an adult C. elegans hermaphrodite (top) and a male (bottom) animal 
In nature, C. elegans dwells in the soil and feeds on bacteria and is therefore in constant 
contact with an environment teeming with microbes. In order to survive, C. elegans is 
protected by physical barriers, the cuticle and the grinder. However, theses barriers offer only 
imperfect protection against microbial entry, as shown by the fact that a small proportion of 
GFP labelled bacteria can pass through the grinder and enter and colonize the intestine 
(Figure 3 and Tan et al., (1999)).  
In the case of Salmonella typhimurium and 
Pseudomonas aeruginosa the bacteria 
accumulate in the intestine of the worm 
and kill the animal (see Figure 3c - 3f). 
The P. aeruginosa-C. elegans interaction 
was used to screen for bacterial clones 
with attenuated virulence (Mahajan-
Miklos et al., 1999). Interestingly, the 
corresponding clones showed also reduced 
virulence in the mammalian model 
proving that the nematode can be used as a 
model for host-pathogen interactions. But 
until recently it was not clear whether C. elegans possesses an immune defence system. 
Although genome analyses revealed the existence of putative antimicrobial peptides, some of 
the components (e.g. Rel/NFκB) in the toll pathway seem to be absent in the worm genome 
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and deletion of the existing genes did not alter the resistance of worms to various pathogens 
(Banyai and Patthy, 1998; Kato et al., 2002; Pujol et al., 2001). By screening for C. elegans 
mutants with enhanced susceptibility to infection by P. aeruginosa several esp genes (esp = 
enhanced susceptibility to pathogens) were identified (Kim et al., 2002). This enhanced 
susceptibility was not specific to the Gram-negative bacterium, P. aeruginosa, because the 
mutants were also hypersusceptible to the Gram-positive pathogen Enterococcus faecalis. 
Cloning of two of these mutants revealed that esp-8 codes for MAP kinase kinase kinase and 
esp-2 codes for a MAP kinase kinase. It has been shown that MAP kinases play an important 
role in the mammalian cellular immune response to lipopolysaccarides (LPS) and therefore it 
can be concluded that C. elegans possesses a conserved and ancient innate immune pathway 
(Dong et al., 2002). Microarray analysis of worms infected with Serratia marcesens revealed 
that animals can, if challenged with a pathogen, induce the expression of various genes e.g. 
lectins and lipases (Mallo et al., 2002). Lipases have been shown to be induced upon infection 
of D. melanogaster and lectin binding motifs are known to be involved in recognition of 
pathogens (De Gregorio et al., 2001; Fujita, 2002). Therefore C. elegans is obviously able to 
respond to infection with the induction of a set of defence genes. Table 1 shows an overview 
of bacteria capable of infecting C. elegans. 
Species Reference 
Gram-positive 
Bacillus megaterium (Andrew and Nicolas, 1976) 
Bacillus thuringiensis (Borgonie et al., 1995) 
Enterococcus faecalis (Garsin et al., 2001) 
Microbacterium nematophilum (Hodgkin et al., 2000) 
Staphylococcus aureus (Garsin et al., 2001) 
Streptococcus pneumoniae (Garsin et al., 2001) 
Gram-negative 
Burkholderia pseudomallei (O'Quinn et al., 2001) 
B. thailandensis (O'Quinn et al., 2001) 
B. cepacia (Tan and Ausubel, 2000); (O'Quinn et al., 2001) 
Pseudomonas aeruginosa (Tan et al., 1999) 
P. fluorescens (Tan et al., 1999); (Darby et al., 1999) 
Salmonella typhimurium (Aballay et al., 2000); (Labrousse et al., 2000) 
Serratia marcescens (Pujol et al., 2001); (Kurz and Ewbank, 2000) 
Yersinia pestis (Darby et al., 2002) 
Yersinia pseudotuberculosis (Darby et al., 2002) 
Table 1: Known bacterial pathogens of C. elegans 
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A pathogen specific for C. elegans and closely related nematodes has been described recently 
(Table 1). Worms grown on bacterial lawns containing Mircobacterium nematophilum 
develop a variably swollen post-anal 
region named deformed anal region 
phenotype (Dar). The swelling is not 
due to cell proliferation as shown by the 
fact that the C. elegans conditional cell 
division mutant stu-7 still exhibits a 
swollen post-anal region if infected 
with M. nematophilum. The animals 
become constipated due to the swelling 
and therefore feed less which results in 
a slower growth rate (see Figure 4). The 
M. nematophilum infection is novel and 
distinctly different in nature from the 
toxicity of some strains of P. aeruginosa for C. elegans. A large screen with previously 
characterized mutants showed that certain mutants with altered surface antigenicity, notably 
srf-2, srf-3 and srf-5, are resistant to infection by M. nematophilum. Currently, it is not clear if 
the swelling is due to an activation of a host defence system or due to a subversion of a host 
cellular process by the bacteria. In order to understand the mechanism of infection and the 
induced swelling a screen for mutants showing normal growth rate and the absence of 
swelling was performed (Bacterially UnSwollen (Bus) phenotype; (Gravato-Nobre et al., 
2001)). The recovered mutants could be grouped into 18 complementation groups and 4 
mutants (e2789, e2680, e2689 and e2797) failed to complement srf-3(yj10).  
 
The surface of nematodes: C. elegans srf mutants 
Parasitic nematodes can survive for long periods in otherwise immunocompetent hosts 
(Maizels and Selkirk, 1988). First evidence how parasitic nematodes can defy the host 
immune system came from studies with Trichnella spiralis. Radiolabelling experiments of  T.  
spiralis surface indicated that the cuticle of this nematode is a dynamic organ which showed 
dramatic changes at the molecular level during the moulting process and gradual 
modifications during growth within a stage (Philipp et al., 1980). Since then, stage-specific 
expression of surface-associated antigens has been described for several species of parasitic 
nematodes (Philipp and Rumjanek, 1984). The outermost layer of the nematode cuticle, the 
Figure 4: Comparison of feeding rates in the presence 
and in the absence of M. nematophilum CBX102. Arrow 
indicates the time scale representing the time at which 
descendants from one single hermaphrodite consumed 
available bacterial food (○□ E. coli; ●■ E.coli + 0.1% M. 
nematophilum). Growth rates for wild type and for srf-2
mutants are shown. The figure was taken from Hodgkin et 
al., (2000).  
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surface coat that is only loosely attached to the epicuticle, is a remarkable dynamic structure 
implicated in antigen shedding. Antigen shedding is thought to be an important parasite 
defence mechanism against antibody-mediated immune effector mechanisms (Blaxter et al., 
1992). The problem is that the study of most parasitic nematodes is always limited by the 
paucity of worm material because parasites are often very hard to grow under laboratory 
conditions due to their complicated life-cycles including several specific hosts. Therefore it 
was very desirable to find an appropriate model organism for parasitic nematodes. Besides its 
experimental advantages, the use of C. elegans as a model for parasitic nematodes is justified 
for the following reasons: First of all, the overall architecture of the cuticle in almost all 
nematodes is similar, it is composed of five layers: surface coat, epicuticle, cortical, median 
and basal layers (see Figure 5). All nematodes follow the same developmental programme: 
the zygote gives rise to the five somatic tissue founder cells followed by the germ line founder 
cell and postembryonic development proceeds through 5 stages separated by moults. 
 
 
 
 
 
 
Figure 5: Schematic representation of an adult C. elegans cuticle. On the left side the 5 layers of the cuticle 
and the underlying structures (hypodermis, basement membrane and muscle sacromeres) are indicated. On the 
right side the components which can be found within a specific layer are listed. Figure is taken from 
http://www.wormatlas.org/handbook/cuticle/cuticle.htm (Blaxter and Robertson, 1998)  
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Figure 6: A phylogenetic hypothesis for the phylum Nematoda based on the SSU-sequence dataset. The 
tropic ecology of the taxa is represented by coloured icons (shown in the upper left corner). Branch lengths 
are drawn to be proportional to the number of changes inferred from the consensus. The major clades are 
indicated (I-V). C+S indicates the clade Chromadoria plus Secernentea; S+P indicates Secernentea plus 
Plectidea. Taken from Blaxter et al, (1998)
 10
A phylogenetic analysis using the sequence of small subunit sequences (SSU) from 53 taxa 
suggested a deep intercalation of free-living and parasitic life modes in the phylum Nematoda 
(Figure 6). According to this phylogenetic relationship C. elegans is most closely related to 
the vertebrate parasitic Strongylida (Blaxter et al., 1998). This finding strongly supports the 
idea that the advances arising from the C. elegans work can be applied at least to some 
parasitic nematode species.  
In order to examine if C. elegans expresses stage-specific surface antigens a polyclonal rabbit 
antiserum prepared against total cuticle proteins of adult wild type worms (Bristol N2) was 
adsorbed on intact larvae. The resulting antiserum was no longer able to bind to the surface of 
larvae but to the surface of adult worms (Politz et al., 1987). Therefore, it was concluded that 
C. elegans expresses stage-specific surface antigens. Interestingly, the cuticle of other wild 
type isolates, e.g. PA-1 or Bergerac BO, failed to label with the corresponding antibody 
suggesting an antigenic polymorphism. This antigenic polymorphism was mapped on 
Chromosome II suggesting that a single gene or gene cluster controls the expression of the 
adult class of surface antigens. The corresponding locus was named srf-1 (surface antigenicity 
abnormal).  To understand the mechanism underlying the Srf phenotype a genetic screen for 
mutants with altered surface antigenicity was performed (Politz et al., 1990).  To do so the 
anti-adult antiserum used to identify srf-1 was depleted of anti-surface antibodies by 
adsorbing it onto intact adult worms. Then worms were mutagenized with ethyl 
methansulphonate (EMS) and animals labelling with the adsorbed antiserum were maintained. 
This led to the identification of two new loci: srf-2(yj262) on Chromosome I and srf-3(yj10) 
on Chromosome IV.  Radioiodination experiments revealed that several components of the 
wild type cuticle were undetectable or less readily labelled in extracts from srf-2 and srf-3 
animals, most notably a non-collagenous, hydrophobic, non-glycosylated heterodimeric 
protein composed of 12 kDa and 6.5 kDa subunits (Blaxter, 1993). Therefore, it was proposed 
that the mutations caused a loss of components from the cuticle surface which led to the 
exposure of antigenic determinants usually hidden in the wild type cuticle.  
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A second independent evidence that C. elegans expresses stage specific surface antigens came 
from a study with a monoclonal antibody (Hemmer et al., 1991). A mouse monoclonal 
antibody named M38 was found to bind specifically to the cuticle of wild type L1 larvae. A 
biochemical characterization revealed that the epitope recognized by M38 was pronase and O-
glycanase sensitive suggesting that it is an O-linked glycoprotein.  In order to find factors 
regulating the timing of antigen expression, an EMS screen for mutants showing altered M38 
binding was performed. This led to the discovery of srf-6(yj43), a mutant where the L1 
specific antigen is expressed at all larval stages. In protein extracts made from srf-2(yj262) 
and srf-3(yj10) animals the antigen was not detectable. Furthermore, a srf-6(yj43); srf-3(yj10) 
double mutant was antigen defective as the srf-3(yj10) mutant alone showing that the srf-6 
phenotype requires srf-3 activity.   A putative O-linked epitope as the antigen of M38 is 
consistent with the finding that the surface coats of nematodes are polyanionic and contain 
carbohydrate and mucin-like proteins (Himmelhoch and Zuckerman, 1983; Jansson et al., 
1986; Page et al., 1992; Zuckerman et al., 1979). Cuticle surface binding of lectins has been 
reported for free-living and parasitic nematodes (Rudin, 1990; Zuckerman et al., 1979). C. 
elegans N2 animals stained with fluorescein isothiocyanate conjugated wheat germ agglutinin 
(FITC-WGA) show labelling at the hermaphrodite vulva and labelling at the male tail (see 
Figure 7). In a screen for mutants showing ectopic WGA binding various mutants were 
identified (see Figure 7 and Link et al., (1992)). Complementation analysis revealed that the 
45 mutants found could be assigned to 6 complementation groups, notably the previously 
described genes srf-2 and srf-3 as well as the newly identified genes srf-4, srf-5, srf-8 and srf-
9. All genes show a highly penetrant ectopic lectin binding phenotype in both sexes, but 
males show a stronger posterior staining if compared to hermaphrodites. Besides the ectopic 
Figure 7: A N2 male (A) and a srf-3(yj10) (B) male stained with WGA-FITC. In N2 only the male tail 
shows fluorescence, whereas in srf-3 animals the tail plus the posterior part of the animal is labelled. Scale 
bar represents 100 µM (Photographs taken by Jörg Höflich). 
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lectin binding, srf-2, srf-3 and srf-5 animals show wild type gross morphology whereas srf-4, 
srf-8 and srf-9 mutants are uncoordinated, have distinct body morphology, a protruding vulva, 
a progressive egg laying defect and show male infertility. Based on the additional phenotypes 
observed in some mutants, srf animals have been divided into two classes: pleiotropic (srf-4, 
srf-8 and srf-9) and non-pleiotropic (srf-2, srf-3 and srf-5) srf mutants. A srf-4 srf-8 srf-9 
triple mutant was phenotypically indistinguishable from the corresponding single mutants 
suggesting that these mutants act in a linear pathway. Double mutants between the pleiotropic 
and the non-pleiotropic mutants have not been reported yet. Nevertheless, the differences in 
the phenotypes of the non-pleiotropic mutants compared to pleiotropic mutants suggest that 
both classes are involved in distinct biological and molecular processes. This idea is further 
supported by the fact that the mutants resistant to infection by M. nematophilum are 
exclusively the non-pleiotropic srf mutants (Hodgkin et al., 2000).  
 
Aim of the thesis 
Many mutants with altered surface antigenicity have been described since now but none of 
these mutants have yet been identified on the molecular level. Although it has been proposed 
that these mutants are involved in glycosylation or secretion, it is impossible to draw any 
conclusions without knowing the molecular identity of the srf genes. The resistance of the 
non-pleiotropic srf mutants to infection by M. nematophilum offers an assayable phenotypic 
marker to clone these mutants. In order to get first insights into the molecular and genetic 
network underlying the surface phenotype and the resistance to infection by M. 
nematophilum, I decided to clone and characterize srf-3.  
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Results 
srf-3 animals are resistant to infection by M. nematophilum and to biofilm 
formation of Yersinia pseudotuberculosis 
N2 worms grown on agar plates containing M. nematophilum CBX102 develop a post-anal 
swelling (see Figure 8A). The distortion of the anal region prevents the defecation muscles 
from working properly and therefore the infected animals become constipated. The 
constipated animals grow more slowly and therefore feed less (Figure 4). srf-3 animals have 
also been reported to be resistant to infection by M. nematophilum (Hodgkin et al., 2000) and 
as can be seen in Figure 8B and Table 2, all srf-3(yj10) worms grown on a Eschericha coli OP 
50 lawn containing 0.1% M. nematophilum do not exhibit a Dar phenotype. Additional srf-3 
alleles have been identified in a screen for Bus mutants (see Introduction), showing that this 
resistance is not allele specific. In order to characterize the novel alleles (gift of Jonathan 
Hodgkin, Oxford), the penetrance of the Dar phenotype of individual srf-3 mutants was 
compared (Table 2). All alleles except srf-3(e2797) show a 100% resistance (no animals with 
a deformed anal region) to the infection by M. nematophilum. srf-3(e2797) animals are only 
partly resistant at 15 and 20°C but fully resistant at 25°C, indicating that e2797 is a 
temperature-sensitive allele.  
Under unfavourable environmental conditions, C. elegans can develop into an alternative 
third-stage larva specialized for dispersal and long-time survival (Riddle, 1988). Dauer larvae 
show a remarkable resistance to environmental stress, e.g. they survive one hour treatment in 
1% sodium dodecyl sulphate (SDS), a property routinely used to enrich or purify dauers from  
Figure 8: srf-3 animals are resistant to infection by M. nematophilum. Normarski differential 
interference contrast (DIC) photographs of the tail region of a N2 animal (A). The Dar phenotype, 
characterized by a distinctive swollen tail, is clearly visible. The arrows indicate the distended intestinal 
lumen characteristic for constipation. (B) A srf-3 animal grown on plates containing M. nematophilum. Tail 
region is indistinguishable from worms grown on standard E. coli OP 50 food source. Scale bar represents 
20 µM. 
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cultures. srf-3 dauer larvae have been reported to be sensitive against SDS treatment of one 
hour, probably due to their altered cuticle (Politz et al., 1990). To test if the dauer larvae of 
the novel srf-3 alleles exhibit a similar phenotype, they were crossed into a daf-2(e1370) 
mutant background. daf-2(e1370) is a temperature sensitive mutant involved in a insulin 
signalling pathway controlling dauer formation (Gottlieb and Ruvkun, 1994). At the 
restrictive temperature (25°C) all daf-2(e1370) L1/L2 animals enter the dauer pathway 
independent of the environmental conditions. The dauer larvae of all tested alleles, notably 
e2789, e2689, e2680 and e2797 showed SDS sensitivity identical to srf-3(yj10). Therefore it 
can be concluded that all srf-3 alleles show a similar behaviour, not only in terms of 
resistance, but also in terms of the SDS sensitivity of their dauer larvae. srf-3 mutants have 
been originally isolated due to their altered surface antigenicity (see Introduction) and 
therefore it seems most likely that the resistance is due to altered surface properties of the 
cuticle, which may alter the adherence or recognition of the bacteria. To evaluate the 
specificity of the srf-3 pathogen resistance, the resistance to other pathogens was tested. 
C. elegans has recently described as a model to examine biofilm formation of Yersinia 
pseudotuberculosis and Yersinia pestis, the latter which is the causative agent of plague 
(Darby et al., 2002). A biofilm can be defined as a microbial derived sessile community 
characterized by cells that attach to a substratum or interface, embed in a matrix of 
extracellular polymeric substance, and exhibit an altered phenotype with respect to growth, 
gene expression and protein production (Shirtliff et al., 2002). After initial surface attachment, 
extracellular replicating bacteria very often develop biofilms which increases adherence and 
allows them to survive in a hostile environment. Biofilm forming bacteria play an important 
role in contaminating medical implants, for example Streptococcus staphylococci, P. 
aeruginosa, S. aureus, S. epidermidis, or in the case of lung infections of cystic fibrosis 
patients (P. aeruginosa) and a characterized by their remarkable antibiotic resistance as 
compared to their planktonically grown counterparts (Davey and O'Toole, 2000).  
 
Table 2: Penetrance of Dar phenotype in N2 and srf-3 animals on plates containing M. nematophilum 
T wild type 
(N2) 
yj10 e2789 e2680 e2797 e2689 br6 
25°C 100% 
(n=322) 
- 0% 
(n=238) 
- 0% 
(n=279) 
- - 
20°C 100% 
(n=403) 
0% 
(n=543) 
0% 
(n=464) 
0% 
(n=395) 
19% 
(n=243) 
0% 
(n=460) 
0% 
(n=135) 
15°C 100% 
(n=183) 
- 0% 
(n=253) 
- 22% 
(n=385) 
- - 
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Y. pestis is transmitted by the bites of infected fleas whose digestive tracts are blocked by a 
mass of bacteria. Blockage is dependent on the hemin storage (hms) locus which is required 
for biofilm formation (Darby et al., 2002; Hinnebusch et al., 1996). When C. elegans is 
exposed to Y. pestis or the closely related bacterium Y. pseudotuberculosis, a biofilm becomes 
visible on the worms’ head (Figure 9A). The biofilm increases in size by continued exposure 
Table 3: Y. pseudotuberculosis biofilm formation on N2 animals and on srf-3 animals* 
T wild type 
(N2) 
yj10 e2789 e2680 e2797 e2689 br6 
25°C 7.9% 
(n=764) 
- - - 56.7% 
(n=716) 
- 99.5% 
(n=664) 
20°C 3.4% 
(n=(641) 
100% 
(n=420) 
100% 
(n=680) 
100% 
(n=528) 
1.4% 
(n=452) 
100% 
(n=725) 
99.4% 
(n=436) 
15°C 0% 
(n=395) 
- - - 1.8% 
(n=365) 
- 98.9% 
(n=201) 
Table 4: Fecundity* of N2 and different srf-3 alleles on plates containing standard OP50 as food source and on 
plates containing M. nematophilum. 
Strain Escherichia coli OP50 Escherichia coli OP50 + 0.1% M. nematophilum 
N2 310 ± 05 (n=15) 144 ± 09 (n=16) 
srf-3(yj10) 285 ± 09 (n=20) 260 ± 07 (n=20) 
srf-3(e2798) 248 ± 09 (n=18) 259 ± 06 (n=20) 
srf-3(e2680) 262 ± 20 (n=17) 241 ± 19 (n=20) 
srf-3(e2797) 272 ± 08 (n=18) 231 ± 13 (n=20) 
srf-3(e2689) 253 ± 12 (n=18) 295 ± 08 (n=20) 
Figure 9: srf-3 animals are resistant to biofilm formation of Y, pseudotuberculosis. Biofilm formation of 
Y. pseudotuberculosis on wild type (N2) and srf-3 animals. DIC photographs of the head region of a N2 (A) 
and srf-3 (B) animal grown on plates containing Y. pseudotuberculosis. (A) Biofilm at the head becomes 
visible within an hour and increases in size during continuing exposure. (B) No biofilm appears in a srf-3
mutant (Bah phenotype). Photographs taken by Creg Darby (Birmingham, Alabama)  
* given is the percentage of the number of total L4’s to the number of total worms (see also Material and 
Methods). The numbers in Table 3 show the average of three independent experiments. 
*given is the number of progeny (mean ± SD) counted as L4 animals. n represents the number of hermaphrodites 
analysed. 
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and covers the head of the animal. This leads to a severe impairment of feeding which in the 
case of C. elegans larvae leads to delayed development or growth arrest. Interestingly, there is 
no sign of colonization of interior tissues of the exposed animals (Darby et al., 2002). 
Therefore it seemed reasonable to test mutants with altered surface antigenicity for resistance 
to biofilm formation of Y. pseudotuberculosis. srf-3 animals had no biofilm and grew 
normally in the continuous presence of Yersinia, and are therefore Bah (Biofilm Absent on 
Head) (Figure 9B). Table 3 shows that all srf-3 alleles are resistant to biofilm formation of Y. 
pseudotuberculosis. srf-3(e2797) animals are only resistant at 25°C confirming the finding of 
the M. nematophilum interaction that this allele is a temperature-sensitive allele.  
Furthermore, an additional srf-3 allele, br6, could be identified in an N-ethyl-N-nitrosourea 
(ENU) induced mutagenesis for animals showing the Bah phenotype (Creg Darby, personal 
comm.). srf-3(br6) animals are also resistant to infection by M. nematophilum. Therefore srf-3 
resistance to infection by M. nematophilum is not limited to one species, as shown by the fact 
that this mutant seems to be unaffected in the presence of two distinct, unrelated bacterial 
species.  To examine additional consequences of srf-3 mutations, the brood size was 
determined. Measuring the amount of progeny produced by a single worm is a sensitive 
indicator for the viability of a certain strain. On standard Escherichia coli OP50 plates the 
number of progeny from the tested srf-3 alleles was in the range of or slightly lower when 
compared to N2 worms (Table 4). On plates containing 0.1% M. nematophilum the 
Figure 10: M. nematophilum cannot adhere to the surface of srf-3 animals. Fluorescence and DIC 
photographs of srf-3 (A) and N2 (B) animals grown on plates containing M. nematophilum and subsequently 
stained with Syto 13. Arrow in B indicates the bacteria adhering to the surface. The tail of the N2 animal in B at 
higher magnification (C).  The black bar represents 100µM. 
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number of progeny of N2 worms was only 50% compared to the brood size of srf-3 alleles 
demonstrating that srf-3 mutants are barely affected by M. nematophilum. It has been 
proposed that the resistance of the non-pleiotropic srf mutants is due to a change in the 
surface properties of the cuticle, which may alter adherence or recognition by the bacteria 
(Hodgkin et al., 2000). However, it is also possible that the bacteria can adhere to the cuticle 
of srf animals but fail to induce the post-anal swelling. To answer this question worms were 
grown on plates containing M. nematophilum and stained with the dye Syto13, which stains 
nucleic acids of live cells, under conditions where bacteria are stained preferentially. In N2 
animals the bacteria adhere to the walls of the rectum and to a small patch of cuticle behind 
the anus (Figure 10B and C). There is no visible staining at the surface of srf-3 animals 
(Figure 10A) and therefore it can be concluded that M. nematophilum fails to infect srf-3 
mutants because the bacteria cannot adhere. The adherence of Yersinia is mediated by the 
biofilm polysaccharide and there is no evidence for signalling between Yersinia and C. 
elegans (L. Tan and C. Darby, personal comm.). Therefore, it can be concluded that resistance 
against two unrelated bacterial strains that use different pathogenic strategies can be conferred 
by mutations in a single factor, srf-3. 
 
srf-3 codes for a protein similar to nucleotide sugar transporters (NSTs) 
To better understand the mechanism underlying the resistance it was crucial to determine the 
molecular identity of srf-3. srf-3 was initially mapped to the right of unc-22 on Chromosome 
IV (Politz et al., 1990). Three factor crosses placed srf-3 between unc-31 and lev-1, close to 
unc-31 (Libby, 1998). In order to clone srf-3, 15 cosmids were chosen which cover a 300kb 
region to the right of unc-31 (Figure 11). Injection of cosmid pools as well as injection of 
single cosmids showed that one cosmid, M02B1, was sufficient to restore the infection of M. 
nematophilum in srf-3 animals.  M02B1 carries 39 kb of genomic DNA containing 5 
predicted ORFs. To narrow down the region required for srf-3 activity subclones of M02B1 
were generated (Figure 12). Transgenic animals carrying an array generated with a clone 
constructed by deleting 17 kb in M02B1 via PacI failed to rescue which indicated that the 
ORFs M02B1.4 and M02B1.3 are not coding for srf-3. In contrast, a subclone covering 13.8 
kb of M02B1 (pBY1454) showed rescuing activity. This clone carried two predicted open 
reading frames, M02B1.1 and ZK896.9, both annotated as coding for proteins similar to 
mouse CMP-sialic acid transporters (http://www.wormbase.org). To identify the ORF 
providing srf-3 activity two separate deletions within pBY1454 were generated.  
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Figure 12: M02B1.1 provides srf-3 activity. Bar on top represents M02B1. Bold bars represent rescuing subclones. 
The number of transgenic lines tested for rescue is shown at the right (rescue/tested). The name of the generated 
constructs is indicated at the right side. Position of the restriction sites which have been used to generate the 
corresponding subclone are indicated with an arrow. Position and size of the predicted ORFs are shown below the bar 
representing the cosmid. The rescuing ORF is written in bold.
Figure 11: The cosmid M02B1 rescues the srf-3 resistance to M. nematophilum. A schematic diagram of the 
physical map in the genomic region of srf-3 covering approximately 300kb. The squares represent the cosmids in 
the region where srf-3 was mapped. Red squares are cosmids which failed to rescue and the cosmid in green 
indicates the one which carries rescuing activity.  Cosmid designation is written within the square. The position 
and the size of the cloned gene unc-31 (ZK897.1) is indicated. A transgenic line derived from an injection of a pool 
of cosmids (K10D11, T13E8, F49E11, C39E9 and K04A6) failed to rescue the resistance of srf-3 animals to M. 
nematophilum, as well as lines derived from the injections of the single cosmids F07C6 and ZK896. Lines derived 
from the injection of M02B1 rescued the resistance.    
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A 3.2 kb deletion via Eco52I destroyed the M02B1.1 ORF (pBY1508) and a 4.2 kb SapI 
deletion destroyed the ZK896.9 ORF (pBY1509). Animals of transgenic lines injected with an 
Eco52I deletion in pBY1454 did not show rescue whereas animals of transgenic lines 
generated with a SapI deletion in pBY1454 showed rescue. Therefore it was concluded that 
M02B1.1 is the ORF providing srf-3 activity.  
M02B1.1 was annotated in the database as a gene encoded by 6 exons, however no expressed 
sequence tag (EST) was available (http://www.wormbase.org). To confirm the exon-intron 
structure of srf-3 the cDNA was cloned. Initial attempts to amplify the cDNA from cDNA 
libraries or reverse transcribed RNA with primer annealing to the region of the predicted ATG  
and STOP codon failed. Caenorhabditis briggsae has diverged from C. elegans 
approximately 50 million years ago and is morphological almost indistinguishable from C. 
elegans. Areas of protein coding sequence seem to be conserved between both species 
whereas intergenic regions and introns are not. The genome of this nematode has been 
sequenced and can therefore be used to identify conserved regions between C. briggsae and 
C. elegans (Stein et al., 2003). To check if the exon-intron boundaries of srf-3 are conserved 
the C. elegans genomic region was compared to the corresponding C. briggsae region. This 
suggested that the exon-intron structure of srf-3 differs significantly from the genefinder 
prediction. Additional evidence came from the cloning results in which a PstI derived 
fragment of M02B1 (pBY1451) failed to rescue. According to the C. briggsae-C. elegans 
alignment the 3’ PstI site removed a unpredicted exon which offered an explanation why this 
construct did not rescue the srf-3 resistance to infection by M. nematophilum. RT-PCR from 
N2 RNA and subsequent sequencing revealed that the predicted exon 3 is missing and an 
Figure 13: The genomic srf-3 structure differs from the predicted exon-intron boundaries.  The upper 
diagram represents the predicted exon-intron structure whereas the lower diagram represents the exon-intron 
structure according to the cloned cDNA. Exons are shown as black boxes, introns are shown as lines. Type and 
site of mutation in the different srf-3 alleles are indicated by a bar. Position and size of the deletion in the allele 
br6 is shown by a grey box. 
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additional exon exists downstream of the predicted STOP codon thereby corroborating the 
exon-intron structure of the C. briggsae-C. elegans alignment (Figure 13). Most nematode 
messenger RNAs (mRNAs) have at their 5' end a common 22 nucleotide leader sequence, the 
trans-spliced leader or SL1 (Davis, 1996). The presence of this leader in the srf-3 cDNA was 
verified by the fact that it was possible to amplify the cDNA using a SL1 specific 
oligonucleotide as a forward primer. Therefore it was concluded that the cloned cDNA 
includes the 5’ end (Figure 13). The srf-3 cloning results were confirmed by three additional, 
independent experiments:  a) Injection of dsRNA prepared from the srf-3 cDNA into rrf-
3(pk1426) animals, which show increased sensitivity to RNA interference (RNAi), rendered 
the progeny resistant to infection by M. nematophilum. b) srf-3 animals carrying an array 
which expresses the srf-3 cDNA under the control of the srf-3 genomic 5’ and 3’ regulatory 
elements (pBY1865, see appendix) were susceptible to infection by M. nematophilum. c) 
Sequencing of the srf-3 locus in the different srf-3 alleles revealed mutations within the ORF 
(Figure 13). The reference allele yj10 had a G-A transition in exon 5 (position 707 of the 
cDNA) which leads to a nonsense codon in the protein. e2689 carried a  C-T transition in 
exon 3 (position 424 of the cDNA) leading to a nonsense mutation in the protein. e2680 
showed a  G-A transition in exon 5 (position 734 of the cDNA) leading to a missense codon 
(conserved glycine to glutamate) at amino acid 245 of the protein. e2789, an allele found in a 
transposon induced screen (mutator strain mut-7 (Ketting et al., 1999)), showed the presence 
of a transposable element (Tc1) sequence disrupting the ORF in exon 3. Allele br6 carried a 
110 bp deletion starting 16 bp upstream of the splice donor in exon 3 and extending 16 bp 
downstream of the splice acceptor in exon 4. The temperature sensitive allele e2797, showed 
a destroyed splice acceptor sequence in exon 3 due to a G-A transition. The mutations 
observed in yj10, br6, e2789 and e2689 would lead to a severe truncation of the encoded 
protein and are therefore most likely null alleles. One way to test genetically whether an allele 
is a partial or complete loss of function allele is to cross the corresponding mutant with a 
deletion covering the locus. If the gene product possesses residual activity a further reduction 
of the abundance of this product by reducing the copy number of the gene would result in a 
more severe phenotype whereas in a case of a null mutation no difference in the phenotype 
can be observed. srf-3(e2789) animals were mated with a strain carrying a deletion, sDf22, 
covering the srf-3 locus. srf-3(e2789)/sDf22 heterozygous animals had phenotypes no more 
severe than srf-3(e2789) homozygous animals. This showed that the srf-3(e2789) allele is a 
null allele and therefore, due to their identical phenotypical behaviour, br6, e2689, and e2680 
are also most likely null alleles.    
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Figure 14: Schematic view of NST structure and function.
Blue box represents the membrane of ER or Golgi. Green tubes 
indicate transmembrane domains. Red circles represent 
glycosyltransferases and black circles indicate nucleotide 
sugars.   
srf-3 codes for a 328 aa type III 
transmembrane protein belonging to 
the members of the family of 
nucleotide sugar transporters (NSTs) 
(Figure 14).  Secreted and membrane 
proteins and lipids are often 
glycosylated in the lumen of the 
endoplasmatic reticulum (ER) 
and/or Golgi apparatus. However, 
the substrates for these 
glycosylation reactions, the 
nucleotide sugars, are synthesized in the cytosol or, in the case of cytosinemonophosphate 
(CMP) sialic acid, in the nucleus. Therefore, there must be a transport mechanism capable of 
translocating these nucleotide substrates from their site of synthesis into the lumen of the 
organelles where glycosylation occurs. The existence of such transporters was first confirmed 
when the molecular defect in some glycosylation defective cell lines was discovered. CHO 
Lec8, CHO clone 13 (Stanley, 1985) and MDCK II-RCAr (Brandli et al., 1988) cells which 
have been isolated due to their resistance to plant lectins show a 70-90% deficiency of 
galactose in their glycans. This phenotype was shown to be due to a defect in 
uridindiphosphate (UDP)-galactose transport into Golgi vesicles (Hirschberg et al., 1998). 
Molecular cloning by phenotypic correction of the corresponding mutants led to the 
identification of cDNAs coding for nucleotide sugar transporters and, since then, various 
NSTs with different transport activities and from distinct species have been described 
(Berninsone and Hirschberg, 1998; Gerardy-Schahn et al., 2001). Nucleotide sugar 
transporters are type III transmembrane proteins containing 6-10 membrane spanning 
domains and they localize to the ER or the Golgi apparatus (Figure 14 and 15). The N- and 
C-terminus of a NST faces the cytosolic site and these proteins functions as antiporters 
exchanging the nucleotide sugar with the corresponding nucleotide monophosphate. The 
function of nucleotide sugar transporter is necessary for subsequent addition of the 
corresponding sugar to proteins and lipids in vivo and disruption of this function can lead to 
severe phenotypic consequences (see Discussion).  
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              _____________ 
  
SRF-3     1 ..................................MKTAILIWLTLQNSIHTLLIRYSRAREV..DAMFVSTVAVWLTEVI 
D.melanogaster 1 ........................MNSIHMNANTLKYISLLTLTLQNAILGLSMRYARTRPG..D.IFLSSTAVLMAEFA 
H.sapiens     1 MAAVGAGGSTAAPGPGAVSAGALEPGTASAAHRRLKYISLAVLVVQNASLILSIRYARTLPG..D.RFFATTAVVMAEVL 
S.pombe  1 ....................MAVKGDDVKWKGIPMKYIALVLLTVQNSALILTLNYSRIMPGYDDKRYFTSTAVLLNELI 
 
        _TM1_________          ___________TM2_____ 
              *e2789 
      *e2797                 *STOPe2689 *br6 
SRF-3    45 KCFICLFLVAQEETP....RRFIHALRTQILEQPYDTLKVCIPAMIYIVQNNLFYVAASHLDAATFMITSQLKIFTAAIF 
D.melanogaster 54 KLITCLFLVFNEEGKDA..QKFVRSLHKTIIANPMDTLKVCVPSLVYIVQNNLLYVSASHLDAATYQVTYQLKILTTAMF 
H.sapiens     78 KGLTCLLLLFAQKRGNV..KHLVLFLHEAVLVQYVDTLKLAVPSLIYTLQNNLQYVAISNLPAATFQVTYQLKILTTALF 
S.pombe  61 KLVVCFSVGYHQFRKNVGKEAKLRAFLPQIFGG..DSWKLAIPAFLYTCQNNLQYVAAGNLTAASFQVTYQLKILTTAIF 
 
         ___   ________TM3______         ______________TM4________ 
 
SRF-3    121 TVIILRRSLNRTQWFALAVLFVGVSLVQLQGTKAKES..............SGESP....FVGFVAVVVACCLSGFAGIY 
D.melanogaster 132 AVVILRRKLLNTQWGALLLLVMGIVLVQLAQTEGPTSGSAGGAAAAATAASSGGAPEQNRMLGLWAALGACFLSGFAGIY 
H.sapiens     156 SVLMLNRSLSRLQWASLLLLFTGVAIVQAQQAGGGGP.R...........PLDQNP....GAGLAAVVASCLSSGFAGVY 
S.pombe  139 SILLLHRRLGPMKWFSLFLLTGGIAIVQLQNLNSDDQMS...........AGPMNP....VTGFSAVLVACLISGLAGVY 
 
         _        _________TM5_________      ___________TM6_______ 
                     *STOPyj10*G-E e2680 
SRF-3    183 FEKILKGSAPVSLWMRNVQMAVFSIPASFSAIYMQDSKTVNEYGLLYGFDSIVWLTVLWYGVGGLSVAVCIKYADNIAKN 
D.melanogaster 212 FEKILKG.AEISVWMRNVQLSLLSIPFGLLTCFVNDGSRIFDQGFFKGYDLFVWYLVLLQAGGGLIVAVVVKYADNILKG 
H.sapiens     220 FEKILKG.SSGSVWLRNLQLGLFGTALGLVGLWWAEGTAVATRGFFFGYTPAVWGVVLNQAFGGLLVAVVVKYADNILKG 
S.pombe  204 FEKVLKD.TNPSLWVRNVQLSFFSLFPCLFTILMKDYHNIAENGFFFGYNSIVWLAILLQAGGGIIVALCVAFADNIMKN 
 
         ________TM7______     __________TM8__________ 
 
SRF-3    263 FATSVAIILSTIGSIFLFDFIPSFTFLLGASLVIFSIFLY....SSHQSMVAALGRLRG.......EIPSTKEAFCL... 
D.melanogaster 291 FATSLAIIISCVASIYIFDFNLTLQFSFGAGLVIASIFLY....GYDPARSAPKPTMHGPGGDEEKLLPRVMNSIHMNAN 
H.sapiens     299 FATSLSIVLSTVASIRLFGFHVDPLFALGAGLVIGAVYLYSLPRGAAKAIASASASASGPCVHQ..QPPGQPPPPQLSSH 
S.pombe  283 FSTSISIIISSLASVYLMDFKISLTFLIGVMLVIAATFLY......TKPESKPSPS.RG..T....YIPMTTQDAAAKDV 
 
 
SRF-3        ................................................................................ 
D.melanogaster 367 TLKYISLLTLTLQNAILGLSMRYARTRPGDIFLSSTAVLMAEFAKLITCLFLVFNEEGKDAQKFVRSLHKTIIANPMDTL 
H.sapiens     377 RGDLITEPFLPKLLTKVKGS............................................................ 
S.pombe  350 DHKH............................................................................ 
 
 
SRF-3           . 
D.melanogaster 447 K 
H.sapiens          . 
S.pombe      . 
 
 
 
 
 
 
 
 
Figure 15: SRF-3 is similar to the family of nucleotide sugar transporters. Alignment of SRF-3 with functionally 
characterized UDP-galactose/UDP-N-acetylgalactosamine (GalNAc) transporter from Drosophila melanogaster
(Accession number: BAB62747; (Segawa et al., 2002)), UDP-galactose transporter from Homo sapiens (Accession 
number: P78381; (Miura et al., 1996)) and UDP-galactose transporter Schizosaccharomyces pombe (Accession 
number: P87041; (Segawa et al., 2002)). Identical residues are shaded in black whereas similar residues are shaded with 
grey. Predicted transmembrane domains of SRF-3 are shown with lines. Missense and nonsense mutations or the end of 
the native protein are indicated with asterisks. The names of the corresponding alleles are written in italics.
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srf-3 is expressed in a set of active secretory cells 
In order to understand in which cells srf-3 function is required, the expression of a srf-3::gfp 
construct was analysed. To do so the srf-3 genomic region was cloned into C. elegans 
expression vectors generated by Andrew Fire (Fire et al., 1990 and 
ftp://www.ciwemb.edu/pub/FireLabInfo/FireLabVectors/). In the first place a construct was 
made where a SRF-3 green fluorescent protein (GFP) translational fusion is expressed under 
the control of the srf-3 regulatory elements (Figure 16.1). GFP is a autofluorescent protein 
from the jellyfish Aequoria victoria which enables the direct observation of the spatial and 
temporal distribution of proteins in living animals (Chalfie et al., 1994; Prasher et al., 1992). 
The GFP signal is first visible in embryogenesis, in a lateral stripe of hypodermal cells, 
called lateral seam cells. Seam cells lie along the apical midline of the hypodermis, at the 
extreme left and right sides between nose and tail (see Figure 25 in the Discussion). Seam 
cell expression started in late embryos and continued until L4 stage, and later disappeared in 
adult animals after the L4/adult moult was completed (Figure 16.2 A-C). srf-3 expression 
was also visible in the glandular cells g1 and g2, in the second bulb of the pharynx,. 
Expression in these gland cells started in L1 larvae and was maintained through adulthood 
(Figure 16.2 C and D). In adult animals expression became also visible in the spermatheca 
(Figure 16.2 C and E). The intracellular GFP localization showed a perinuclear staining 
reminiscent of an ER or Golgi resident protein (Figure 16.2 F). Expression in males 
resembles the observed pattern in hermaphrodites: glandular cells, seam cells and the vas 
deferens, a male structure which is functional similar to the spermatheca in hermaphrodites 
(data not shown). To test whether the observed expression pattern reflects the distribution of 
the native gene the corresponding array was crossed into a srf-3 mutant background. srf-3 
(e2789) unc-30(e191) animals carrying an array expressing srf-3::gfp were susceptible to 
infection by M. nematophilum and therefore it was concluded that the array is expressed in 
all tissues required for proper srf-3 function. However, it is still possible that the reporter 
gene is present at low levels in other tissues than the described ones and therefore cannot be 
detected with GFP. To exclude this possibility, a C-terminal, translational fusion of SRF-3 
and β-galactosidase protein encoded by the E. coli lacZ gene was constructed (Silhavy and 
Beckwith, 1985) (Figure 17.1). An extremely sensitive assay for the detection of β-
galactosidase activity is the cleavage of the chromogenic substrate X-Gal (5-bromo-4-chloro-
indolyl-β-D-galactoside) which leads to an accumulation of a blue precipitate. 
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Figure 16: SRF-3::GFP is localized to the lateral seam cells, glandular cells g1 and g2 and spermatheca.
16.1: Structure of the expression construct pBY1605. GFP was fused to the N-terminus of SRF-3 (M02B1.1) and 
expressed under the control of srf-3 5’ and 3’ regulatory elements.  Magenta coloured bar indicates srf-3
promoter and the khaki coloured bar represents the srf-3 genomic coding region. The white boxes show the 
position of the multiple cloning sites (MCS) region  16.2: Localization of a SRF-3::GFP fusion. For each GFP 
the corresponding DIC is shown below. Unless otherwise indicated the scale bar represents 10µm. (A) Seam cell 
expression in late embryo prior to hatching. (B) Seam cell expression in L2 larvae. (C) SRF-3 expression in an 
adult hermaphrodite. Spermatheca expression is indicated by white arrows, expression in the glandular cell g1 by
an asterisk. (D) g1 expression at higher magnification  reveals strong fluorescence in the cell bodies and a very 
weak fluorescence of processes (white arrows). (E) Spermatheca expression at higher magnification. (F) 
Intracellular SRF-3::GFP localization shows a perinuclear staining.  Photograph is taken from a seam cell of an 
L2 larva.   
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Due to the enzymatic activity of the β-galactosidase the signal in the lacZ reporter system 
undergoes a strong amplification leading to a more sensitive assay as compared to GFP, 
where every molecule represents a single fluorophore. Animals transgenic animals for srf-
3::NLS::lacZ showed β-galactosidase staining in the lateral seam cells (Figure 17.2 A,C), the 
glandular cells g1 and g2 (17.2 A,D) and the spermatheca (Figure 17.2 B). Therefore, the 
17.1 
Figure 17: SRF-3::NLS::LACZ is localized to seam cells, glandular cells g1 and g2 and spermatheca. 
17.1: Structure of the expression construct pBY1907. β-galactosidase was fused to the C-terminus of SRF-3 
(M02B1.1). Magenta coloured bar indicates srf-3 promoter and the khaki coloured bar represents the srf-3
genomic coding region. The white box shows the position of the multiple cloning site (MCS) region. 17.2: β-
galactosidase staining of a L4 larvae (A). The blue lines are the lateral seam cells. Glandular cells are indicated 
with arrows. Spermatheca (arrow) expression in an adult hermaphrodite (B). Seam cell expression in an L2 
larva showing both rows of lateral seam cells (C). Glandular cell expression at higher magnification (D). 
Visible are four cell bodies (arrows) in the posterior bulb. The anterior cells are dorsal and ventral g1 and the 
posterior ones are the dorsal and ventral g2. Unless otherwise indicated scale bar represents 100 µM.  
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expression pattern of the β-galactosidase fusion was indistinguishable from the GFP reporter 
fusion and it was concluded that the observed expression pattern represents the full 
expression detectable by reporter gene analysis. As shown in Figures 16.1 and 17.1, the used 
expression constructs differ with respect to their 3’ untranslated region (UTR). The construct 
pBY1605 contains the srf-3 3’UTR whereas pBY1907 carries an unc-54 3’UTR 
implemented in the Fire vectors to ensure efficient processing of C. elegans transcripts in the 
analysis of reporter expression constructs. The expression of both construct was 
indistinguishable suggesting that the srf-3 3’UTR does not contain any important regulatory 
elements that cannot be substituted by unc-54.  
The cuticle of srf-3 animals is fragile to handling as indicated by the fact that mutant animals 
show a low survival rate after injections and srf-3 dauer larvae are sensitive to SDS treatment 
(Politz et al., 1990). The observed srf-3 expression led to the speculation that the described 
fragility of the cuticle can be attributed to a defect in the seam cells. To address this question 
an integrated array expressing ajm-1::gfp, which localizes localizing to the apical borders of 
the C. elegans  epithelium (Mohler et al., 1998) was crossed into a srf-3 mutant background. 
ajm-1::gfp expression in srf-3 animals was indistinguishable from N2 animals (data not 
shown) suggesting that at least number and shape of seam cells in srf-3 mutants are 
unaffected (see Figure 25 for the position of the apical junctions).  
To test if srf-3 expression is altered upon infection, transgenic animals carrying an array 
containing srf-3::gfp were infected with M. nematophilum. Pattern and intensity of srf-3::gfp 
was undistinguishable from uninfected worms suggesting that srf-3 expression is not 
modulated by the infection.  
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Figure 18: VSV-SRF-3 is expressed in S. cerevisiae.
Immunoblotting of protein extracts made from S.
cerevisiae cells transformed with vector alone or cells 
expressing srf-3 cDNA fused with a single VSV-G tag 
(VSV-SRF-3) coding sequence. P represents the
membrane fraction and S represents the cytosolic 
fraction. 
SRF-3 transports UDP-galactose and UDP-N-acetylglucosamine  
The analysis of the srf-3 primary sequence suggested a high similarity to nucleotide sugar 
transporters (Figure 14). This finding infers a critical role of glycosylation in regulating 
surface antigenicity. Determination of the substrate specificity of SRF-3 can demonstrate that 
this protein is able to function as a nucleotide sugar transporter and may help to understand in 
which way carbohydrate structures or glycosylated proteins are utilized by the bacteria. The 
substrate specificity of a certain NST cannot be deduced from the sequence alone but has to 
be determined experimentally. For example, the murine CMP-sialic acid transporter shows 
40% amino acid sequence identity to a human UDP-galactose transporter, yet both 
transporters are highly substrate specific (Hirschberg et al., 1998). SRF-3 is 61% similar to 
Drosophila UDP-Gal/UDP-GalNac and 60% similar to a murine CMP-sialic acid transporter, 
however a mass spectrometry analysis 
suggested that C. elegans does not have 
sialic acid (Bacic et al., 1990). To identify 
the substrates translocated by SRF-3, the 
VSV tagged protein was expressed in S. 
cerevisiae. To determine the substrate 
specificity ER/Golgi enriched vesicles were 
isolated maintaining their in vivo 
topography and assayed for their ability to 
transport radiolabelled nucleotide sugars 
(see Material and Methods). Before the 
transport assay was performed it was ensured by immunoblotting that the protein is expressed 
in yeast (Figure 18). The VSV antibody detected a signal with an apparent molecular weight 
of 29 kDa in membrane fractions of cells transformed with a construct expressing vsv-srf-3 
but not in cells transformed with the vector alone. The molecular weight is consistent with a 
32 kDa protein predicted from the translation of the srf-3 cDNA and therefore it was 
concluded that SRF-3 is expressed in S. cerevisiae. S. cerevisiae exhibit an intrinsic UDP-
glucose transporter activity (Hirschberg et al., 1998), a characteristic which can be used to test 
the quality of the isolated vesicles. Vesicles prepared from yeast cells expressing vsv-srf-3 and 
cells transformed with the vector alone transported UDP-glucose in a comparable manner and 
were therefore of similar quality (Figure 19A). UDP-galactose and UDP-N-acetylglucosamine 
were transported into ER/Golgi enriched vesicles prepared from yeast cells expressing srf-3 
but not from vesicles prepared from yeast cells transformed with the vector control.  
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Figure 19: SRF-3 is able to transport UDP-galactose and UDP-N-acteylglucosamine into S. cerevisiae
ER/Golgi-enriched vesicles. 19 A) Transport activity is displayed as amount of nucleotide sugars inside the 
vesicles at 30°C minus the corresponding amount at 0°C. Results shown are an average of six independent assays 
from two independent vesicle preparations. Black bars represent S. cerevisiae transformed with pG426 and white 
bars represent cells transformed with pG426-vsv-srf-3. B) Saturation curve for the transport of UDP-Gal and UDP-
GlcNAc. Transport of substrate is plotted against the concentration of the corresponding nucleotide sugar. 
Abbreviations are: UDP-Glu (UDP-glucose), UDP-Gal (UDP-galactose), UDP-GlcNAc (UDP-N-
acetylglucosamine), UDP-GlcA (UDP-glucuronic acid), UDP-GalNAc (UDP-N-acetylgalactosamine), GDP-Fuc 
(GDP-fucose), CMP-Sia (CMP-sialic acid). 
A 
B 
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No transport of UDP-glucuronic acid, UDP-N-acetylgalactosamine, GDP-fucose or CMP-
sialic acid was detected in either srf-3 or vector control vesicles. The analysis of the transport 
characteristics revealed that the substrates were transported with an apparent Km of 5.9 µM 
for UDP-Gal and 20µM for UDP-GlcNAc (Figure 19B). SQV-7, a previously described C. 
elegans nucleotide sugar transporter with multisubstrate specificity has a Km of 4 µM for 
UDP-GlucA, 8.7 µM for UDP-GalNAc and 4.6 µM for UDP-Gal and, therefore, the measured 
Km values are in close agreement with previously described nucleotide sugar transporters 
(Berninsone et al., 2001). Hence, in vitro, SRF-3 is able to transport UDP-Gal and UDP-
GlcNAc in a saturable and temperature dependant manner.   
Another approach to determine the substrate specificity is to express the cDNA of interest in a 
mutant defective in a specific transporter and then assay phenotypic correction. To confirm 
the results from the S. cerevisiae experiments SRF-3 was expressed in mutants defective for 
UDP-Gal and UDP-GlcNAc transport.  A Kluyveromyces lactis mutant with a defect in a 
Golgi resident UDP-GlcNAc transporter has been described (Abeijon et al., 1996a). This 
mutant shows a lack of N-acetylglucosamine in its outer mannan chains (Smith et al., 1975) 
leading to a differential binding of Griffonia simplicifolia II (GSII) lectin which recognizes 
terminal α− and β-linked N-acetylglucosamine.  By transforming K. lactis with a cDNA 
library made from MDCK cells and subsequent labelling with FITC-conjugated GSII lectin  a 
mammalian UDP-GlcNAc transporter was isolated (Guillen et al., 1998). This showed that 
the K. lactis system can be used for expression and identification of heterologous NSTs. K. 
lactis KL3 cells transformed with a construct expressing srf-3-vsv showed a increased GSII 
binding as compared to cells transformed with the vector alone (Figure 20A). Therefore, it 
can be concluded that SRF-3 is able to transport UDP-GlcNAc into the Golgi of K. lactis 
cells.  The S. cerevisiae data also suggest UDP-Gal as a substrate for SRF-3 (Figure 19). The 
Madin-Darby canine kidney (MDCK) cell line RCAr was isolated due to the resistance to the 
toxin ricin (Meiss et al., 1982). RCAr cells grow at ricin concentrations 10 times higher 
compared to wild type MDCK cells. Ricin consists of two subunits, the α subunit, an N-
glycosidase which is required for inhibition of protein synthesis and the β subunit, a lectin 
domain required for uptake of ricin into the cell (Sandvig and Van Deurs, 2002).  Uptake of 
ricin requires binding to terminal galactosyl residues and resistance of RCAr cells is in 
agreement with an undergalactosylation of glycoproteins and glycolipids (Brandli et al., 
1988). It was shown that this defect is linked to a Golgi localized UDP-Gal transporter and 
this system has been used to find substrates of previously unknown nucleotide sugar 
transporters  (Berninsone et al., 2001; Ishida et al., 1996). MDCK RCAr cells transfected with 
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the vector alone grew at all concentrations tested whereas cells transfected with constructs 
expressing N- or C-terminal tagged SRF-3 were only viable up to a concentration of 0.25 
ng/ml (Figure 20B). Hence, SRF-3 can restore the ricin sensitivity in RCAr mutants and is 
therefore able to transport UDP-Gal into the Golgi lumen of MDCK cells.  Taken together 
these results demonstrate that SRF-3 is able to transport UDP-Gal and UDP-GlcNAc into the 
lumen of the ER and/or Golgi in vitro and in vivo.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: SRF-3 corrects the phenotypes of mutants defective in UDP-GlcNAc and UDP-Gal transport. A) 
K. lactis mutant KL3 which is defective for UDP-GlcNAc transport was transformed with srf-3-vsv (white bar) and 
shows restored Griffonia simplicifolia II (GSII) lectin labelling. The vector control (black bar) is KL3 mutant 
transformed with K. lactis expression vector pE4. B) MDCK cells transfected with N and C-terminal VSV-tagged 
SRF-3 were grown in the presence of different ricin concentrations and subsequently stained with Methylen blue. 
The SQV-7 UDP-Gal translocator activity has been described previously and served as a positive control. The 
vector control represents MDCK RCAr cells transfected with pCDNA3.1 vector alone. Three independently 
isolated clones were tested in each case.  
A B
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Genetic interactions of srf-3 
In order to find mutants genetically interacting with srf-3, previously described mutants with 
similar phenotypic properties and mutants of genes known to be involved in glycosylation 
were tested for resistance to M. nematophilum. Furthermore it was examined if double 
mutants between srf-3 and other srf mutants or mutants affected in glycosylation would result 
in animals with more severe phenotypes.  
bre (Bacillus-toxin resistant) mutants have been isolated in a screen for animals resistant to 
killing by the Bacillus thuringiensis δ-endotoxin Cry5B and one bre mutant, bre-5(ye17), was 
shown to code for a putative β-1,3-galactosyltransferase (Griffitts et al., 2001; Marroquin et 
al., 2000). However, neither bre-5(ye17) nor any of the other bre mutants (Appendix, Table 5) 
showed resistance to infection by M. nematophilum.  
Mutants with a lumpy, amorphous ray morphology (Ray morphology or Ram phenotype) 
have been shown to exhibit increased WGA-FITC binding (Ko and Chow, 2000). All of the 
tested ram mutants (all ram mutants listed in Table 5 in the Appendix have been tested) 
exhibit a strong Dar response on plates containing M. nematophilum and were therefore not 
resistant.  
Various deletion mutants of glycosyltransferases have been generated, notably gly-1(ev686), 
gly-2(qa703), gly-12, gly-13, gly-14, gly-16(qa701) and gly-18(qa704) (see Table 5 and 
Warren et al., (2001); Warren et al., (2002); Chen et al., (2002); Chen et al., (2003)). Despite 
of gly-13, which is embryonic lethal, none of the gly mutants exhibit a visible phenotype and 
none of the mutants was resistant to infection by M. nematophilum. Moreover, animals of 
double mutants between srf-3 and gly-2, gly12, gly-14, gly-16 and gly-18 did not show any 
obvious phenotypes as judged by visual inspection.  
srf mutants can be grouped into pleiotropic and non-pleiotropic mutants (see Introduction). A 
triple mutant between the pleiotropic mutants, srf-4, srf-8 and srf-9 was indistinguishable 
from the corresponding single mutants suggesting that these genes act in a linear pathway 
(Link et al., 1992). To further understand the genetic relationship between the srf mutants, a 
srf-3; srf-4, a srf-2; srf-3, a srf-3; srf-5 and a srf-2; srf-5 double mutant was generated (see 
Table 5). Double mutants between the non-pleiotropic srf mutants were viable, showed 
similar lectin binding and did not show any other obvious phenotypes.  However, a srf-3; srf-
4 double mutant was zygotic embryonic lethal demonstrating that the combined disruption of 
the biological processes to which srf-3 and srf-4 contribute, are essential for proper C. elegans 
development.  
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Analysis of the genomic region of the srf-3 locus revealed the existence of an additional 
putative NST, ZK896.9, adjacent to srf-3. Cloning and sequencing of the ZK896.9 cDNA 
showed that the cDNA is spliced in trans to a SL1 and SL2 leader sequence and therefore 
contained the true 5’ end. The observed SL2 suggests that both transporters, srf-3 and 
ZK896.9, are organized within an operon. In C. elegans an operon is a cluster of closely 
spaced genes, transcribed from a regulatory region at the 5’ end of the cluster, and whose 
monocistronic mRNAs are generated from an polycistronic precursor mRNA accompanied by 
trans-splicing to SL2 or a mixture of the two SLs (Blumenthal and Steward, 1997). 
Furthermore, the cloning of the cDNA confirmed that the exon-intron structure was correctly 
predicted by genefinder. ZK896.9 shows 38% identity and 52% similarity on protein level to 
SRF-3. It was tested whether ZK896.9 has a complementary expression pattern to srf-3 and 
might therefore provide SRF-3 function in other tissues. To address this question, an 
expression construct in which GFP is fused to the C-terminus of ZK896.9 and which 
contained 2.8 kb of 5’ sequence was generated (pBY1564, see Appendix). Transgenic animals 
carrying an array expressing ZK896.9::GFP showed a GFP signal in a pair of yet unidentified 
sensory neurons (Figure 22). Therefore ZK896.9 shows an expression pattern distinct from 
srf-3. To get a first insight into ZK896.9 function, RNAi was performed. Neither feeding 
bacteria containing dsRNA transcribed from the ZK896.9 cDNA nor injection of dsRNA 
made from the same cDNA, in N2 or rrf-3(pk1426) animals, resulted in worms with visible 
phenotypes. To test if simultaneous disruption of srf-3 and ZK896.9 function would lead to 
animals with more severe phenotypes, srf-3 animals were subjected to ZK896.9 RNAi 
(feeding). However no additional phenotypes were observed in the corresponding animals.  
 
 
Figure 21: Genomic region of srf-3. A schematic representation of approximately 8 kb of genomic region of 
srf-3. ZK896.9 a nucleotide sugar transporter similar to SRF-3 is 1.7 kb downstream of the M02B1.1 ORF. The 
grey box indicates size and position of the deletion in the by158 allele. Exons are represented by black boxes. 
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Due to the fragile cuticle resulting in low survival rates, injection of ZK896.9 dsRNA into srf-
3 worms was not feasible. In order to further understand ZK896.9 function a deletion mutant 
of this gene was generated (see Material and Methods). by158 deleted 2.4 kb of ZK896.9 
genomic region removing 700 bp of sequence upstream of the ATG plus the first three exons 
and is therefore most likely a null allele (Figure 21). Animals homozygous for by158 did not 
show any obvious, visible phenotypes and were not resistant to M. nematophilum suggesting 
that the function of this gene is not essential for C. elegans development. Injection of srf-3 
dsRNA into by158 animals also didn’t result in animals with more sever phenotypes, hence 
srf-3 and ZK896.9 seem to have distinct and unrelated functions in the worm.  
Figure 22: GFP expression pattern of ZK896.9. A) DIC photograph of an adult hermaphrodite. B) GFP signal 
in the same worm. Visible is a pair of yet unidentified sensory neurons (processes are indicated with arrows.  C)
Overlay of A and B.  Bar represents 10 µM.  
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Discussion 
The aim of the thesis was to understand the molecular mechanisms underlying the resistance 
of srf-3 animals to the bacterial pathogens Microbacterium nematophilum and Yersinia 
pestis/pseudotuberculosis.  M. nematophilum adheres to the cuticle of wild type animals but 
fails to adhere to the surface of srf-3 worms. This is a novel type of resistance because 
pathogens like P. aeruginosa or Salmonella typhimurium do not adhere to the cuticle but kill 
C. elegans by colonization and accumulation in the intestine. srf-3 was identified by 
molecular cloning which showed that this gene codes for a transmembrane protein belonging 
to the family of nucleotide sugar transporters. Expression analysis revealed that SRF-3 is 
expressed in a set of active secretory cells consistent with a function of this gene in cuticle or 
surface modification.  Heterologous expression of the srf-3 cDNA showed that SRF-3 is able 
to transport UDP-galactose and UDP-N-acetylglucosamine. The results presented in this 
thesis strongly suggest that the inability of Y. pseudotuberculosis and M. nematophilum to 
adhere to the cuticle is due to an altered glycoconjugate composition of the srf-3 surface.   
 
 
srf-3, glycosylation and bacterial adherence 
In order to be able to cause an infection a certain pathogen has to colonize its host. 
Colonization of hosts by microorganisms starts with a non-specific aggregation on certain cell 
types, e.g. the gut epithelium, followed by a specific adhesion to distinct host cell receptors 
and thereby defines the tropism of an infectious agent. Adhesion is achieved by microbial 
adherence factors called adhesins (Hacker, 2002). Adhesins, which are produced by all forms 
of pathogens e.g. viruses, fungi, bacteria and eukaryotic parasites are surface-exposed proteins 
with a special structure that enables them to interact with certain host receptors. Adhesin-
receptor interactions very often trigger signal transduction events on bacterial and on the host 
side which are critical for colonization and infection (Hauck, 2002). Adhesive structures used 
by bacteria are proteins like fimbrial and non-fimbrial adhesins or polysaccharides 
(lipopolysaccharides (LPS), exopolysaccharides (EPS)) or lipoteichoic acids (LTA). Host 
structures utilized for adhesion by extracellular replicating microorganisms are very often 
components of the extracellular matrix (ECM) like integrins, cadherins and molecules of the 
immunoglobulin superfamily (IgCAMs) (Hauck, 2002). All of these components are 
glycoproteins and consistent with this finding most of the known binding sites of adhesins are 
glycoconjugates (Karlsson, 1998; Ofek et al., 2003). For example, Yersinia pestis and 
Bordetella pertussis have filamentous haemagglutinin (FHA) related proteins which have 
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been shown to be able to recognize and bind heparan sulphate proteoglycans (Menozzi et al., 
2002). 
Mutations in srf-3 were isolated because the corresponding animals showed an altered surface 
antigenicity and pathogen resistance and therefore it is not surprising that the adherence of 
bacteria to the surface of this mutant is affected. The fact that the C. elegans cuticle is covered 
by a carbohydrate rich surface coat strongly suggests that an altered glycosylation pattern in 
srf-3 mutants is the cause for the failure of M. nematophilum to adhere to the worm’s surface. 
But what kind of receptors does M. nematophilum recognize and how? M. nematophilum has 
been discovered recently and no sequence information and no tools for genetic manipulations 
are available which might help to address these questions. There are some information about 
adhesion of Y. pestis and Y. pseudotuberculosis which both fail to form a biofilm on srf-3 
animals. By testing attenuated Y. pseudotuberculosis strains found in a transposon induced 
screen in a murine yersiniosis model Wren and coworkers identified six strains also showing 
altered biofilm formation in C. elegans  (Joshua et al., 2003). Two of these mutants showed 
defects in genes required for LPS biosynthesis. LPS is an important component in the outer 
bacterial membrane and has powerful biological effects in mammals, including fever, septic 
shock and a variety of deleterious effects. Furthermore, it plays a crucial role in initial surface 
attachment of P. aeruginosa and E. coli (Davey and O'Toole, 2000) and an important role in 
effective colonization of host tissues in Yersinia species (Skurnik, 2003). However, the exact 
role of LPS in adherence remains largely unexplained and the C. elegans – Yersinia/M. 
nematophilum interaction might provide a valuable tool to further examine and understand the 
host and the bacterial processes involved in adherence on a biotic surface.  
 
srf-3 is a nucleotide sugar transporter 
To gain an insight into the molecular mechanisms underlying the altered surface antigenicity 
and the altered pathogen resistance, the molecular identity of srf-3 was determined in this 
thesis. srf-3 codes for a NST. All alleles carried mutations in the locus leading to a truncated 
or aberrant protein. e2797, the temperature sensitive allele, is a splice mutant. In C. elegans  ts 
mutants are frequently observed to carry mutations in splice sites (Choy and Thomas, 1999; 
Röhrig, 2000). e2680 carries a G-A transition leading to a  glycine to glutamic acid exchange 
in the predicted transmembrane domain 6 (see Figure 15). The sequence at this position in 
wild type SRF-3 is VGGLSVA (residues in bold are conserved, Figure 23) with the first 
glycine being exchanged in e2680. A similar mutation was found in CHO cells of the 
complementation group Lec8 (Oelmann et al., 2001) where a glycine to aspartic acid 
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exchange at the position 281 occurred (sequence D84454 in Figure 23). This position is 
highly conserved within mammalian NSTs 
specific for UDP-Gal and CMP-Sia 
transport, as well as in SRF-3 (Figure 23). 
Consistent with the results from srf-
3(e2680) as being a complete loss of 
function allele, a similar mutation in the 
hamster gene rendered the UDP-Gal 
transporter non-functional. What are the 
consequences of this mutation? There is 
evidence that this position is crucial for the 
formation of an active transporter. 
Expression of a cDNA coding for the mutated hamster transporter in CHO K1 cells showed 
that the mutant protein is correctly localized arguing against a defective  targeting of the 
molecule (Oelmann et al., 2001). Mutating the same position in a murine CMP-Sia transporter 
led to non functional protein showing that the corresponding amino acid residue is not 
involved in substrate recognition because CMP-Sia and UDP-Gal differ structurally with 
respect to their nucleotide and sugar part. Further evidence is coming from experiments with 
chimeras generated by exchanging segments of a human UDP-Gal and a human CMP-Sia 
transporter (Aoki et al., 2003; Aoki et al., 1999). Analysis of the substrate specificity and 
transport activity of these chimeras indicated that the C-terminal domain of NSTs is involved 
in generating an active transport site and might participate in the motile process required to 
translocate nucleotide sugars across the membrane. So one explanation why e2680 is 
genetically a null allele is that the transporter is correctly targeted and maybe recognizes its 
substrates, but fails to translocate them across the membrane. However, additional binding 
and kinetic studies with mutant transporters have to be performed to definitely answer this 
question.  
Transport of nucleotide sugars into the Golgi lumen is necessary for subsequent addition of 
sugars to proteins, lipids and glycosaminoglycans (GAGs). The pathophysiological relevance 
of NSTs is demonstrated in the case of congenital disorder of glycosylation type IIc (CDG 
IIc) which leads to immunodeficiency and severe mental and psychomotor defects. On the 
molecular level the disease is characterized by a generalized lack of fucosylated 
glycoconjugates, including immunological important selectin ligands and it was shown that 
this defect is due to a defect in a guanosinediphosphate (GDP)-fucose transporter (Lübke et 
Figure 23: Sequence alignment of a highly 
conserved region in mammalian NSTs. Point 
mutation (lec8) identified in a hamster UDP-Gal 
transporter is given in the top lane. Numbers in 
parentheses indicate the amino acid with which the 
domains start. Taken from (Gerardy-Schahn et al., 
2001) 
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al., 2001; Lübke et al., 1999). An additional example is the human UDP-Gal/GalNAc Golgi 
transporter: Overexpression of the corresponding transporter is directly related to the 
metastatic capacity of colon cancer (Kumamoto et al., 2001). 
Another example for phenotypic consequences of a defect in a transporter comes from the 
protozoal parasite Leishmania donovani which causes visceral leishmaniasis. The surface of 
this organism is covered by a mannose rich lipophosphoglycan (LPG). LPG is the critical 
receptor for L. donovani for recognition and entry into the macrophage and is generally 
required for the parasite’s growth and survival in its host. This is shown by the fact that L. 
donovani mutants defective in LPG biosynthesis grow well in vitro but fail to grow in their 
vector, the sand fly, and fail to infect macrophages (Descoteaux and Turco, 1999). One 
avirulent mutant, LPG2, was shown to code for a GDP-mannose transporter (Descoteaux et 
al., 1995). This mutant synthesizes only truncated LPGs lacking the characteristic repeating 
saccharide units.  
The aforementioned examples show that an alteration of NST activity can lead to severe 
changes in the subsequent addition of sugars to proteins and lipids in vivo and therefore to 
severe phenotypic consequences due to an altered glycosylation pattern.  
Since now only one other C. elegans NST has been described in detail. Mutations in any of 
the eight squashed vulva genes (sqv) resulted in animals showing defects in vulva 
invagination and maternal effect lethality. The molecular identity suggested that these genes 
may act in a glycosylation pathway and one of the genes, sqv-7, encoded a protein similar to 
NSTs. As described above, defects in NSTs can lead to severe phenotypes and in accordance 
with this finding the null phenotype of sqv-7 is embryonic lethal (Hwang and Horvitz, 2002). 
In contrast, the disruption of srf-3 function results in animals which are viable and 
morphological indistinguishable from wild type animals. Analysis of the C. elegans genome 
led to the identification of 16 NST like proteins (Gerardy-Schahn and Eckhardt, 2000) with 
only three now being described in more detail. SQV-7 is a transporter with multisubstrate 
specificity capable of translocating UDP-Gal, UDP-GlcA and UDP-GalNAc (Berninsone et 
al., 2001), C50F4.14 was shown to transport GDP-Fuc (Lühn et al., 2001) and  SRF-3 
transports UDP-Gal and UDP-GlcNAc (this thesis). Therefore, it is possible that the transport 
activities provided by SRF-3 can at least in part be fulfilled by other yet unidentified 
transporters. However, a mass spectroscopy analysis of glycan composition revealed that the 
abundance of complex glycans containing galactose were severely reduced in C. elegans srf-3 
as compared to wild type animals (John Cipollo, Boston University, pers comm.) indicating 
that a loss of srf-3 function leads to consequences on the molecular level in vivo.  
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Figure 24: Neighbour joining phylogenetic tree of NST 
family 1. Subfamily A are CMP-Sia, subfamily B are UDP-
GlcNAc and subfamily C are UDP-Gal/GalNAc transporters.
Subfamily D and E have not been functionally characterized. 
Arrow indicates SRF-3. Bootstrap values next to divergence 
points have been circled. The scale bar represents the number 
of substitutions per site for a unit branch length. Figure was 
taken from (Martinez-Duncker et al., 2003). 
The biochemical data show that 
SRF-3 is capable of transporting 
UDP-Gal and UDP-GlcNAc, a 
combination of substrate specificities 
not previously described.  A 
phylogenetic analysis led to the 
arrangement of 87 NST like 
sequences into three clades with 
SRF-3 being grouped into family 1 
(Martinez-Duncker et al., 2003). 
However, due to the low bootstrap 
values SRF-3 was not assigned to 
subfamily C, the UDP-Gal/GalNAc 
transporters (Figure 24). The 
biochemical results suggest now that 
SRF-3 indeed is a member of the 
subfamily of UDP-Gal transporters. 
It has been proposed that the 
transporters of subfamily C, due to 
their substrate specificity (UDP-Gal/UDP-GalNAc), utilize the position of the hydroxyl group 
(OH) group at C4 in the sugar ring to recognize their substrate. In Gal and GalNAc this OH 
group is in the axial position whereas in sugars like Glc, GlcNAc, GlcA and Xylose the OH 
group is in the equatorial position. SRF-3 transports UDP-Gal and UDP-GlcNAc which 
suggests that the position of the OH at C4 is not involved in substrate recognition of these 
transporters.    
Where is SRF-3 localized within the cell? The SRF-3::GFP signal indicates an ER or Golgi 
localization of the transporter which is consistent with the proposed function in glycosylation. 
There is no direct proof but some evidence that SRF-3 is localized in the Golgi membrane. 
The K. lactis UDP-GlcNAc and the MDCK UDP-Gal transporter have been shown to 
function in the Golgi (Abeijon et al., 1996b; Brandli et al., 1988) and therefore SRF-3 has to 
localize to this compartment in these heterologous systems in order to be able to correct the 
corresponding phenotypes. Furthermore, the SRF-3 protein lacks the consensus sequence for 
an C- terminal ER retention signal KKXX (Figure 15) and isolation of Golgi enriched vesicles 
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led to enrichment of VSV-SRF-3 as judged by immunoblotting whereas the isolation of ER 
enriched vesicles did not (Jörg Höflich, unpublished observation).  
 
srf-3 expression pattern and phenotype 
Analysis of the expression pattern by transgenic reporter lines revealed that srf-3 is expressed 
in the lateral seam cells, the glandular cells g1 and g2, and the spermatheca. This expression 
pattern is consistent with the proposed function of srf-3 in cuticle and/or surface modification. 
Each moult is preceded by a lethargus, a period during which pumping and locomotion are 
suppressed. There is evidence that the seam cells play the most active part in cuticle synthesis 
(see Figure 25 for the organization of the hypodermis). Between 2 and 4 hours before 
lethargus, the cytoplasm of the seam cells and to a much lesser extent the hypodermal 
syncytium (hyp7) becomes a granular appearance which is due to densely packed Golgi 
bodies (Singh and Sulston, 1978). In situ hybridization of a collagen probe showed primarily 
hybridization to the hypodermal seam, and much less hybridization to the rest of the 
hypodermis (Edwards and Wood, 1983). Another evidence came from studies with an adult 
specific collagen, col-19 (Thein et al., 2003). Examination of the cuticle of various mutants 
affecting body morphology carrying a COL-19::GFP reporter showed that most of the defects 
in collagen mutants e.g. dpy-5 occurred in the cuticle overlying the seam cells due to the 
failure of these cells to contract properly.  
 
A
C
B
Figure 25: Schematic representation of the organization of the adult hermaphrodite hypodermis cells. (A) 
View of the hypodermis which is composed of two distinct types, the circumferentially contracting lateral seam 
cells (syncytium composed of 15 nuclei on each side) and the laterally contracting ventral-dorsal hypodermis 
(syncytium which contains 92 nuclei). (B) Cross section showing hypodermal and lateral seam cells. (C) The 
positions of the cross sections within the worm are shown.  The seam cells are linked to the hypodermis by very 
small adherens junctions along the full length at their apical borders, and by small gap junctions on their lateral 
membranes. Original figures were obtained from http://www.wormatlas.org/handbook/hypodermis/ 
hypsupportseam.htm. 
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Glandular cell staining is also cuticle/surface related.  First of all the gland cells are active 
during moulting; shortly before ecdysis refractile granules accumulate in the g1 cells and 
move along the processes (see Figure 17.2 D) which open just behind the buccal cavity and 
the anterior bulb (Singh and Sulston, 1978). Secondly, studies with the parasitic nematode 
Toxocara canis have shown that antibodies which have been raised against carbohydrate 
epitopes of secreted (Toxocara excretory-secretory (TES)) antigens  localize to the surface as 
well as to the esophageal glands (Page et al., 1992).  In the same study, T. canis surface 
antigens have also been found to be secreted via the excretory system, an “H” shaped cell 
with lateral columns (Chitwood and Chitwood, 1950). C. elegans possesses a similar cell 
involved in part in kidney function, excreting saline fluid via the duct and pore in order to 
maintain the animal's salt balance (osmoregulation) and probably to remove metabolites 
(Buechner et al., 1999). The lack of srf-3 expression within the excretory system suggests 
that, at least in C. elegans, the excretory apparatus is not involved in regulating surface 
antigenicity. This is supported by the finding that all excretory abnormal (exc) mutants, who 
show a degenerated or pathological changed excretory cell, are all non-Srf as judged by 
WGA-FITC labelling. srf-3 is also expressed in the spermatheca and at 20°C there is no 
obvious fertility phenotype (Table 4, page 18). This suggests that the spermatheca is 
functioning normally with respect to sperm preservation and function, because otherwise 
sperm loss or dysfunction would result in much lower self-fertility. However, at 25°C animals 
of various srf-3 alleles show a low penetrant sterility phenotype (Jörg Höflich, unpublished 
observation) indicating that srf-3 might have a function in modifying or in storing sperm 
properly. The observed embryonic lethality of a srf-3; srf-4 double mutant also indicates that 
srf-3 has a function in the development of the embryo, however, in the moment this function 
remains unexplained. 
Srf-3 expression may also be interpreted from a cell biological point of view: Glycosylation is 
the most extensive posttranslational modification and has a central function for sorting and 
quality control of proteins within the secretory pathway. Seam cells, glandular cells and 
spermatheca are a set of active secretory cells and SRF-3 provides the donor substrates for the 
subsequent glycosylation reactions and therefore affecting not only glycosylation per se but 
also protein trafficking.      
 
What is the biological function of srf-3? 
At the first glance it seems that srf-3 function is dispensable. By visual inspection srf-3 worms 
are undistinguishable from wild type worms and the mutant animals seem to benefit from the 
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resistance to some pathogens which they may encounter in their environment. There is no 
defect in the seam cells, as judged by the ajm-1::gfp staining. Even on an ultrastructural level, 
as judged by standard transmission electron microscopy (TEM) of thin sectioned and fixed 
with OsO4 srf-3 animals, no differences were detected (Castano and Politz, pers. comm.). 
However, there is evidence that srf-3 function has an important function for cuticle 
formation/modification. srf-3 animals are fragile to handling e.g. during microinjection, show 
increased susceptibility to drug treatment and the srf-3 dauer larvae are SDS sensitive (Link et 
al., 1992; Schinkmann and Li, 1992). Radioiodination experiments revealed the absence of 
various compounds from the cuticle in srf mutants (see also Introduction). It was proposed 
that the Srf phenotype in srf-2 and srf-3 animals is a result of an unmasking of antigenic 
determinants which are normally hidden in the wild type cuticle (Politz et al., 1990). Given 
the molecular identity of srf-3 it seems likely that the observed loss of components is due to 
underglycosylation and/or aberrant secretion of molecules usually embedded in the cuticle. 
How can this loss of components and the fragility of the cuticle and on the other side the lack 
of visible structural defects be interpreted? The lack of structural defects observed in the 
ultrastructural analysis can be explained by the experimental limitation due to the fixation 
procedure used in standard electron microscopy, a fixation procedure which does not or only 
poorly preserve the surface coat (Blaxter et al., 1992). Therefore, it is possible that the 
observed phenotypes are due to the lack or the alteration of the worm’s surface coat. This 
would imply that this layer of the exoskeleton has an important function in its 
composition/maintenance, as judged by the defects (fragility, permeability) of the cuticle. 
Consistent with this idea is the finding that the surface coat is a carbohydrate rich structure 
(40% content in T. canis) with extensive O-glycosylation (Khoo et al., 1991) and it seems 
reasonable that a defect in an NST affects especially this structure. With SRF-3 transporting 
UDP-Gal and UDP-GlcNAc many glycosylated structures can be affected and at the moment 
it is unclear in which way the surface is altered. A global altered glycosylation pattern would 
be consistent with the fact that M. nematophilum and Y. pseudotuberculosis fail to adhere to 
srf-3 animals; two bacterial species which are not closely related and therefore are suggested 
to use different mechanisms and utilize different host structures for their interaction with 
worms. 
  
The surface of C. elegans wild type worms binds few if any lectins (see Introduction). 
Attachment of spores of some nematode trapping fungi is restricted to the sensory openings 
and the vulva (Barron, 1977; Jansson, 1994). Therefore, the limited lectin binding of the 
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worm’s surface might reflect a passive defence mechanism which renders the worm 
biochemically less visible for his environment and therefore might help to avoid adhesive 
traps and spores of fungi and bacteria. srf-3 mutants show an ectopic lectin binding phenotype 
and it is interesting to note that srf-3 animals were found to be more susceptible to trapping by 
Duddingtonia flagrans, a nematode predatory fungi (Mendoza De Gives et al., 1999). This 
finding supports the idea of a protective function of surface glycosylation with respect to 
natural enemies. Further supporting results are coming from studies with parasitic nematodes 
which show that the nematode cuticle is a highly dynamic organ which has an important 
function to allow the worms survival in the host (see Introduction). Surface antigens are  
actively released from the animals and various parasitic nematode species have been shown to 
shed surface bound antibodies in vitro (Philipp and Rumjanek, 1984). Mice immunized with 
affinity purified T. spiralis antigens induced level of protection comparable to primary 
infection (Gamble, 1985). The model is that the loosely attached surface coat may slough off 
attached molecules (antibodies or cells in parasitic or spores and bacteria in free-living 
nematodes) and therefore serves as a dispensable sink for enzymatic effector mechanisms 
(Blaxter et al., 1992).   
A lot of information is available on the structure and identity of surface antigens, however, 
nothing is known about the factors regulating the expression of these antigens. Cloning of the 
first C. elegans srf mutant, now offers the opportunity to examine the genetic and molecular 
mechanisms regulating surface antigenicity. For example, one question which can be 
addressed now is: What are the factors which regulate the distribution and timing of srf-3 
expression?  An initial attempt to find genes interacting with srf-3 by testing previously 
described genes, e.g. genes encoding putative glycosyltransferases, did not lead to the 
identification of factors modulating srf-3. However, the combined disruption of the processes 
in which srf-3 and srf-4 are involved in, are essential for proper worm development. At the 
moment this result remains unexplained but maybe the molecular identification of srf-4 will 
shed light on this notion. 
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Material and Methods 
 
Chemicals and Reagents 
If not stated otherwise, chemicals and reagents (analytical grade) were purchased from Merck, 
Sigma, Roth, Fluka and Biorad. Reagents for molecular biology, restriction enzymes and 
other enzymes were purchased from MBI Fermentas, New England Biolabs (NEB), Qiagen, 
Promega, Molecular labs, La Roche and Boehringer Ingelheim.  Media for cultivation of 
bacteria, yeast and worms were obtained from Difco and Gibco BRL. Radiolabelled 
chemicals were purchased from Amersham Pharmacia, Perkin Elmer and American 
Radiolabeled Chemicals.  
 
C. elegans methods and strains 
All Caenorhabditis elegans strains were grown as described (Wood, 1988). Transgenic 
animals were constructed as described (Mello et al., 1991). General methods as freezing 
worms, cleaning contaminated strains and obtaining synchronized populations were done as 
described (Stiernagel, 1999). Injection of dsRNA was done as described (Fire et al., 1998).  
 
Syto13 staining 
To detect bacteria tightly attached to the surface of the animal, worms were stained with Syto 
13 (Hodgkin et al., 2000). Worms were grown on plates containing M. nematophilum for 3-4 
days and washed three times with M9 and resuspended in TBS and incubated for 1 hour to 
remove bacteria loosely attached to the worms. Afterwards worms were incubated with 10µM 
Syto13 in TBS for 30-60 minutes and washed three times with TBS.   
 
Staining C. elegans for β-galactosidase activity 
β-galactosidase staining was done essentially as described (Mounsey et al., 1999). Worms 
were washed off from 1 or 2 five centimetre NGM plates with M9 buffer, which had just been 
cleared from bacteria. Worms were transferred into a 15 ml Falcon tube, washed two times 
with M9 buffer and transferred into 1.5 ml Eppendorf tubes. After centrifugation at 700 g the 
supernatant was removed and the worm pellet was frozen in liquid nitrogen and dried 30 
minutes in a vacuum concentrator. 250 µl of cold acetone were added and the sample was 
frozen for 3 minutes at -20°C. After removing of excess acetone with a pipette, the sample 
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was dried for 30 minutes in a vacuum concentrator. 200 µl of freshly mixed staining solution 
were added and samples were incubated at 37°C. Appearance of the blue colour was 
monitored under a stereomicroscope. Reaction was stopped by washing three times with M9 
buffer. 
 
Staining C. elegans with lectins 
Worms were grown on a standard OP50 food source and washed off the plate with M9. After 
three subsequent washes with PBS, worms were incubated for one hour in PBS and then 
transferred to an Eppendorf reaction tube. Then worms were incubated with 50 µl WGA-
FITC in 1 ml PBS for one hour and subsequently washed three times with 1 ml PBS. 
Afterwards the samples were mounted for microscopy.   
 
Infection of C. elegans with M. nematophilum 
A mixture of E. coli OP 50 and 0.1 % M. nematophilum was grown on NGM plates for 48 h 
at 20°C. To infect worms, animals were transferred from plates containing standard OP 50 
food source to plates with M .nematophilum and allowed to grow for 2 -3 days at 20 or 25°C. 
To determine the penetrance of the Dar phenotype the amount of infected worms was 
compared to the amount of uninfected worms.  
 
Yersinia biofilm formation  
The Yersinia biofilm formation assay was done by Creg Darby (University of Alabama) and 
performed as follows. Yersinia pseudotuberculosis was grown overnight on NGM plates. Five 
adult worms were picked to the Yersinia pseudotuberculosis lawns and were allowed to lay 
eggs for 2-4 hours. After removing the adults the plates were incubated at 20°C for two days 
and the number of L4 animals was compared to the number of total worms. Since the biofilm 
blocks feeding, the resulting percentage serves as an indirect measure of biofilm attachment. 
 
Crosses 
Simple crosses were done as follows: L4/young adult hermaphrodites were mated with males 
at a ratio of 1:3 on 3.5 cm NGM agar plates. Worms were transferred to a fresh plate every 
day for four consecutive days. The success of the cross was monitored by the amount of 
males in the F1 generation.  The double mutant of interest was isolated in the F2 generation.  
srf-3 unc-30 (e191)  double mutants were generated by recombination.  srf-3 males were 
 45
mated with dpy-20 (e1282) unc-30 (e191) hermaphrodites and in the F2 generation non-dpy 
unc recombinants were picked. F3 Unc animals only segregating Unc’s were maintained and 
subsequently tested for the presence of the Srf phenotype by growing on plates containing M. 
nematophilum.  
 
srf double mutants 
All srf double mutants were created by marker exchange. srf-3(e2789); srf-4(ct109) was 
created as follows: srf-4(ct109) hermaphrodites were mated with dpy-20 (e1282) unc-30 
(e191)/+ males. F2 Dpy Uncs were picked segregating srf-4 animals. In the F3 generation 
then srf-4 animals were maintained. dpy-20(e1282) unc-30(e191); srf-4(ct109) 
hermaphrodites were mated with srf-3(e2789) males and  wild type worms were picked in the 
F1. In the F2 srf-4 animals segregating Dpy Uncs and dead eggs were maintained. The 
resulting strain is homozygous for srf-4 and heterozygous for srf-3 with two mutations in 
genes flanking srf-3; dpy-20 and unc-30.  
A srf-(yj262); srf-3(e2789) double mutant was generated as follows: srf-3(e2789) males were 
mated with dpy-5(e61) daf-16(m26) unc-75(e950) hermaphrodites and in the F2 generation 
animals resistant to M. nematophilum segregating Dpy Uncs were picked. In the F3 Dpy Uncs 
animals were picked resulting in the strain dpy-5(e61) daf-16(m26) unc-75(e950); srf-
3(e2789). In parallel, srf-2 males were mated with unc-30(e191) hermaphrodites and Unc 
animals resistant to M. nematophilum were isolated. Next srf-2(yj262); unc-30(e191) males 
were mated with dpy-5(e61) daf-16(m26) unc-75(e950); srf-3(e2789) hermaphrodites. 
Animals homozygous for srf-2(yj262) and srf-3(e2789) were isolated by picking non Dpy non 
Uncs in the F2 generation which do not segregate any Dpy or Unc progeny in the F3. The 
success of the cross was verified by a complementation test using the resistance to M. 
nematophilum as a phenotypic marker. 
The principle for generating a srf-3(e2789); srf-5(ct115) and a srf-2(yj262); srf-5(ct115) 
mutant was equivalent. The strain used to mark srf-5 on Chromosome X was lon-2(e678) unc-
84(e1410).  
 
Deletion library 
To identify a deletion in the ORF ZK896.9, approximately 3 x 106 L4 animals were incubated 
with 50 mM methansulfonic acid ethylester (EMS) for 4 hours. Mutagenized worms were 
kept over night on standard plates and the next day eggs were prepared by hypochlorite 
treatment. L1 larvae were allowed to hatch overnight in M9 buffer and adjusted to the number 
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of 160 larvae/100 µl S-Medium. In parallel E. coli HB101 was grown in 1 liter LB overnight 
at 37°C, harvested by centrifugation and resuspended in S-Medium up to an OD600 of 2. 
HB101 was mixed with L1 larvae at a ration 1:1 and the mix was aliquoted in twenty-four 96 
well plates with 40 larvae per well. After 4-5 days 12.5 µl of each well were pooled and the 
DNA was prepared by Phenol/Chloroform extraction and subsequent ethanol precipitation. 
The DNA was resuspended in Tris/HCl pH 8.0 and was used as a template for PCR.      
 
Worm lysis for Single Worm Polymerase Chain Reaction (PCR) 
Single worms were picked into PCR tubes containing 10 µl of Worm lysis buffer and frozen 
at -80°C for at least 30 minutes. Afterwards the samples were heated up to 95°C for 2 minutes 
and the Proteinasedigest was performed at 65 °C for one hour. One microliter of Wormlysis 
was used as a template for PCR.  
 
Single Worm PCR 
For the isolation of the ZK896.9 deletion mutant or single worm PCR, two rounds of PCR 
were performed using nested primer. The first PCR was done using outer primer pair 
(RB1483/RB1555), 1 µl template, 1U Taq Polymerase (MBI Fermentas) for each reaction, 
annealing temperature of 53°C, 90 seconds elongation time and 35 cycles. The conditions for 
the second PCR were identical to the first PCR except for the primer used (inner primer pair; 
RB1484/RB1557), 0.5 µl first PCR and the annealing temperature (56°C).   
 
Preparation of RNA from C. elegans  
To obtain total RNA of a population of mixed staged animals, 4 to 5 plates with unstarved 
worms were washed off with M9 buffer. After two washing steps with M9 buffer the worms 
were frozen in liquid nitrogen and stored at -80°C until the RNA was prepared.  The frozen 
worms were transferred into a sterile mortar and homogenized with a sterile pestle. 600 µl of 
lysisbuffer were added to the homogenized worms and the resulting extract was transferred to 
a cold 1.5 ml Eppendorf tube. The extract was drawn five to seven times into a 2 ml syringe 
carrying a needle with 0.9 mm diameter. To remove the worm debris the extract was 
centrifuged at 16000 g for ten minutes. The supernatant was transferred to a new cold 1.5 ml 
Eppendorf tube and mixed with an equal volume of 70% ethanol. The RNA was purified with 
the RNeasy Mini Kit from Qiagen according to the manufacturer’s instructions.  The RNA 
obtained from this preparation protocol can be used for Northern blot analysis and RT-PCR.  
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Cell culture methods 
 
Transfection 
Madin-Darby canine kidney (MDCK) cells were stably transfected by lipofection (Felgner et 
al., 1987) using Lipofectin Reagent (Invitrogene). Cells were grown at 37°C in minimal 
essential medium (MEM, GIBCO BRL) supplemented with 10% fetale bovine serum (FBS) 
and 100 U Penicillin/Streptomycin (GIBCO, BRL). For transfection cells were grown in 24 
well plates and transfection was performed when cells reached a confluency of 30-50%. 20 µl 
Lipofectin reagent were diluted into 100 µl Opti-MEM serum free medium (GIBCO-BRL) 
and incubated for 45 minutes at room temperature. 2 µg DNA of the plasmid to transfect were 
mixed with 100 µl Opti-MEM medium, added to the lipofectin-MEM and incubated for 15 
minutes at room temperature. In parallel cells were washed once with Opti-MEM and overlaid 
with 1.8 ml of serum free medium. The Lipofectin-DNA mix was added and the culture was 
incubated for 6 hours at 37 °C. For recovery the medium was removed and the cells were 
grown for 72 hours in complete medium containing FBS and antibiotics. Cells were 
trypsinized and plated at low density in 92 x 16 mm Petri dishes containing MEM medium 
with 0.5 mg/ml geneticin (G418; GIBCO BRL). Plates were continuously monitored for 
surviving cells and resistant colonies were cloned.  
 
Determination of ricin resistance 
Ricin resistance was determined by growing pBY1821 and pBY1825 transfected cells at 30°C 
in 24 well plates containing MEM with various concentration of ricin (RCA II, EY 
Laboratories, San Mateo, CA). After seven days cells were washed three times with PBS and 
survival was determined by staining viable cells with methylen blue. 
  
 
Yeast methods  
Yeast was grown and treated as described (Gietz and Woods, 2002; Sherman, 1991). Yeast 
transformation was done by the PEG/LiAc method described in Gietz and Woods, (2002).  
 
Preparation of a yeast protein extract  
To prepare protein extracts for immunoblotting S. cerevisiae PRY225 cells were transformed 
with pBY1822 and grown in SD-URA media to an OD600 of three and harvested by 
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centrifugation.  The cell pellet was washed with 1 ml deionised water and suspended in 200 µl 
membrane buffer. The cells were disrupted by adding an equal volume of glass beads (200-
300 µm diameter) and subsequent vortexing (3 cycles of one minute vortexing and one minute 
cooling on ice). The supernatant was transferred into a new Eppendorf tube and centrifuged at 
100.000 x g. The pellet (membrane fraction) was kept and the supernatant was transferred into 
a new Eppendorf tube. To concentrate the cytosolic fraction the supernatant was precipitated 
with 10% trichloracetic acid (TCA) centrifuged at 100.000 x g and the pellet was dissolved in 
100 µl membrane buffer. The membrane fraction was mixed with an equal volume of 2x 
Laemmli buffer and incubated for 5 minutes at 65°C prior to loading on a polyacrylamide gel. 
The cytosolic fraction was mixed with an equal volume of 2x protein sample buffer and 
incubated for 5 minutes at 95°C prior to loading on a polyacrylamide gel.  
 
Preparation of Golgi-enriched vesicles from S. cerevisiae 
S. cerevisiae PRY225 cells were transformed with pBY1822 or pG426 were grown in SD-
URA media to an OD600 of 3 and harvested by centrifugation. The cell pellet was resuspended 
in 10 mM NaN3 up to a final volume of 50ml and a equal volume of 2x spheroblast buffer 
containing Zymolase 100T (20 mg per 50 g of cells) was added. Cells were converted into 
spheroblast by shaking the culture for 1 h at 37°C. The cell pellet was suspended in a small 
volume of a membrane buffer and drawn rapidly several times into a narrow-bore serological 
pipette which breaks the cells but maintains the vesicle integrity. After a low speed 
centrifugation step to remove cell debris Golgi enriched vesicles were collected by a high 
speed centrifugation (100.000 x g) and resuspended in 1 ml Membrane Buffer.  
 
Transport assay 
The theoretical basis for the translocation assay was described before (Perez and Hirschberg, 
1987). The assay is only applicable to microsomal membranes which are sealed and have the 
same membrane topography as in vivo. The assay was performed in 1 ml transport buffer with 
500 µg Golgi enriched vesicles, 30°C and in parallel at 0°C for three minutes and a 
concentration of 1 µM for the nucleotide sugar to be measured. To measure the transport 
activity the substrate was mixed with the 1 µCi of the corresponding tritiumlabelled 
nucleotide sugar. To determine the radioactivity, liquid scintillation spectrometry was used. 
After the incubation, the reaction was stopped by dilution with 3 ml stop solution, the vesicles 
were reisolated by ultracentrifugation (supernatant = concentration of nucleotide sugar in the 
incubation medium(Sm)), washed 3 times with ice cold stop solution and suspended in 500 µl 
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H2O. The radioactivity in the corresponding pellet consisted of radiolabelled solutes which 
were transported across the membrane, radiolabel which was adsorbed and radiolabel which 
was transferred to macromolecules. The vesicles were broken by vortexing and the 
macromolecules were precipitated with 8% perchloric acid. After centrifugation at 16.000 x g 
radiolabelled solutes that were transported are in the supernatant (supernatant = amount of 
acid-soluble nucleotide sugars (St)). In order to be able to calculate the amount of transported 
nucleotide sugar the volume outside the vesicles had to be determined. For this purpose, 
vesicles were incubated in a separate reaction with the membrane non-penetrator [3H]-acetate. 
The amount of solutes outside the vesicle (So) was obtained by multiplying the volume 
outside the vesicle Vo with the concentration of nucleotide sugar in the incubation medium 
(Sm). The amount of radioactive sugar inside the vesicles Si was calculated by subtracting the 
amount of radioactive sugar outside the vesicles from the amount of acid-soluble nucleotide 
sugars (Si=St-So). Transport activity was defined as amount of nucleotide sugars inside the 
vesicles at 30°C minus the corresponding amount at 0°C.  
 
Cell surface labelling of K. lactis 
K. lactis cells transformed with pE4-srf-3-VSV or vector alone were grown at 30°C in SD-
URA media and then washed three times with 0.9% NaCl, 0.5mM CaCl2. Approximately 5 
OD600 of cells was resuspended in 100µl of 0.5 mg/ml GSII-FITC in 0.9% NaCl, 4 mM CaCl2 
and incubated for 1h at 30°C with shaking. Samples were washed three times and 
resuspended in 0.9% NaCl, 0.5mM CaCl2. Fluorescence was measured at 535 nm with a 
Tecan microplate reader.    
 
 
 
General molecular biology 
 
General molecular biology methods, protein biochemistry and microbiology methods were 
done as described (Ausubel, 1987; Sambrook et al., 1989). Sequencing was performed by 
GATC (Konstanz). Oligonucleotides for sequencing or PCR were purchased at a desalted 
grade from Metabion GmbH (Martinsried) or MWG Biotech AG (Ebersberg) and HPLC 
purified from Thermo Electron Corporation (Ulm). The extraction of DNA out of agarosegels 
was done with the Qiagen Gel Extraction Kit according to the manufacturer’s instruction. 
Precast Tris/Glycine gels from Biorad were used for polyacrylamide gel electrophoresis.  
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Isolation of plasmid and cosmid DNA from E. coli 
For the isolation of plasmid DNA from E. coli a modified protocol from Birnboim and Doly, 
(1979) was used. The DNA was purified with columns provided by Qiagen according to the 
instructions of the manufacturer. Small DNA amounts were prepared from 5 ml cultures 
whereas larger amounts were purified from 100 ml cultures.  
For the isolation of cosmids the culture was directly streaked out from the stock delivered by 
the Sanger Center (http://www.sanger.ac.uk/Projects/C_elegans/) and incubated at 30°C 
overnight on agar plates containing the appropriate antibiotic. Small (1-2 mm diameter), 
single bacteria clones were picked with a tip of a pipette using a stereomicroscope. 10 ml 
cultures were grown in LB selective medium until OD600 of approximately 1 (12-24h). 10 µl 
of the extracted DNA was loaded on 0.4 % agarose gel. DNA migrating with or above the 20 
kb fragment of EcoRI/HindIII digested lambda DNA and without additional lower bands 
which indicate deletions was considered to be a full length cosmid. To obtain larger amounts 
of the cosmid DNA of interest, cultures were grown in 500 ml LB selective medium and the 
DNA was purified using Qiagen Midi Prep columns.   
 
Polymerase Chain Reaction (PCR) 
Reactions were performed in a volume of 25 µl or 50 µl with 100 ng Plasmid DNA as a 
template and one-fold concentrated reaction buffer with 0.2 mM of each desoxynucleotide 
and oligonucleotides at a concentration of 10 pmol/µl.  For each reaction between 0.25 and 
0.5 U Taq Polymerase or 3 U Pfu Polymerase was used. If the DNA was amplified with Taq 
Polymerase MgCl2 was supplemented to a final concentration of 1 mM. The reaction was 
performed in a MJ PTC-200 cycler.  The following parameters were considered for the 
adjustment of the reaction profile: Quantity and quality of the template DNA, length and G/C 
content of the oligonucleotides, type of polymerase used and length of the expected PCR 
fragment.  
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Appendix 
 
Used and constructed C. elegans  strains 
 
Table 5: used C. elegans  strains 
Strain Genotype Reference 
AT6 srf-2(yj262) I (Politz et al., 1990) 
AT10 srf-3(yj10) IV (Politz et al., 1990) 
BC1217 sDf22/nT1 IV; +/nT1 V (Clark et al., 1988) 
BR2374 unc-31 (e169) srf-3 (yj10) lev-1 (e211) IV this study 
BR2391 unc-31 (e169) srf-3 (yj10) IV this study 
CB2238 lon-2(e678) unc-84(e1410) X CGC  
(provided by B. Horvitz) 
CB5430 srf-3(e2680) ÎV this study 
BR2905 gly-14(id48) III; gly-12(is47) X (Chen et al., 2003) 
CB5439 srf-3(e2689) IV this study 
CB5608 srf-3(e2789) IV this study 
CB5670 srf-3(e2797) IV; him-5(e1490)V this study 
CL183 him-5(e1490) srf-4(ct109)V (Link et al., 1992) 
CL208 srf-9(dv4) him-5(e1490)V (Link et al., 1992) 
CL261 him-5(e1490)V; srf-5(ct115)X (Link et al., 1992) 
CL264 srf-8(dv38)V (Link et al., 1992) 
DP? unc-119(ed4)III (Maduro and Pilgrim, 1995) 
DA491 dpy-20 (e1282) unc-30 (e191) IV CGC (provided by L. Avery) 
DC1047 srf-3(br6) IV this study 
DR210 dpy-5(e61) daf-16(m26) unc-75(e950)I CGC  
(provided by M. MacMorris )
DR66 daf-13(m66)X (Riddle et al., 1981) 
DR466 him-5(e1490) V (Hodgkin et al., 1979) 
EM68 col-34(bx25) IV; him-5(e1490)V (Baird and Emmons, 1990) 
EM81 him-5 (e1490) V ram-5( (bx30) X (Baird and Emmons, 1990) 
EM113 dpy-10(e128) ram-3(bx32) II him-5(e1490) V (Baird and Emmons, 1990) 
EM131 ram-2(bx39) II him-5(e1490) V (Baird and Emmons, 1990) 
EM139 ram-1(bx34) I him-5(e1490) V (Baird and Emmons, 1990) 
HY483 bre-3(ye26) III (Marroquin et al., 2000) 
HY485 bre-4(ye27) IV (Marroquin et al., 2000) 
HY494 bre-2(ye31) III (Marroquin et al., 2000) 
HY496 bre-1(ye4) IV (Marroquin et al., 2000) 
HY498 bre-5(ye17) I (Marroquin et al., 2000) 
NJ51 exc-1(rh26) X (Buechner et al., 1999) 
NJ242 exc-2(rh90)X (Buechner et al., 1999) 
NJ555 exc-3(rh207) X (Buechner et al., 1999) 
NJ683 exc-7(rh252) II (Buechner et al., 1999) 
NJ731 exc-5(rh232)IV (Buechner et al., 1999) 
NJ833 exc-6(rh103) III (Buechner et al., 1999) 
NL2099 rrf-3(pk1426) II (Simmer et al., 2002) 
NW1287 gly-1 (ev686) II (Warren et al., 2001) 
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Strain Genotype Reference 
MT6169 exc-4(n2400) I (Buechner et al., 1999) 
 MT6984   exc-9(n2669) IV (Buechner et al., 1999) 
XA762 gly-2(qa703) I (Warren et al., 2002) 
XA763 gly-16(qa701) I (Warren et al., 2001) 
XA749 gly-1(qa702) II (Warren et al., 2001) 
SU93 jcIs [pJS191, pRF4, unc-29(+)] IV (Mohler et al., 1998) 
 
 
Table 6: constructed C. elegans  strains 
Strain Genotype 
BR2408 srf-3(e2789) unc-30(e191) IV 
BR2416 srf-3(e2680) unc-30(e191) IV 
BR2438 srf-3 (e2680) unc-30 (e191)IV byEx238 [M02B1, BSSKII, pBY218] 
BR2439 srf-3(e2789) unc-30(191)IV byEx239 [M02B1, BSSKII, pBY218] 
BR2440 srf-3(e2680) unc-30(e191)IV byEx239 [M02B1, BSSKII, pBY218] 
BR2443 srf-3(e2789) unc-30(e191)IV; byEx241 [ZK896, BSSKII, pBY1153] 
BR2444 srf-3(e2789) unc-30(e191)IV; byEx242[ZK896, BSSKII, pBY1153] 
BR2461 srf-3(e2689) unc-30(e191) IV 
BR2515 srf-3(e2789) unc-30(e191)IV; byEx262 [pBY1453, BSSKII, pBY1153] 
BR2516 srf-3(e2789) unc-30(e191)IV; byEx263 [pBY1453, BSSKII, pBY1153] 
BR2517 srf-3(e2789 unc-30(e191) IV; byEx264 [pBY1453, BSSKII, pBY1153] 
BR2520 srf-3(e2789) unc-30(e191)IV; byEx266 [pBY1454,BSSKII, pBY1153] 
BR2521 srf-3(e2789) unc-30(e191) IV; byEx265 [pBY1454, BSSKII, pBY1153] 
BR2563 srf-3(e2789) unc-30(e191) IV; byEx276 [pBY1509, BSSKII, pBY1153] 
BR2564 srf-3(e2789) unc-30(e191) IV; byEx277 [pBY1509, BSSKII, pBY1153] 
BR2569 srf-3(e2789) unc-30(e191) IV; byEx280 [pBY1508, BSSKII, pBY1153] 
BR2572 srf-3(e2789) unc-30(e191) IV; byEx281 [pBY1508, BSSKII, pBY1153] 
BR2597 unc-31(e928) srf-3(yj10) IV; him-5 (e1490) V 
BR2625 unc-30(e191) IV; him-5(e1490) V 
BR2655 srf-3(yj10) unc-30(e191) IV 
BR2675 srf-3(e2680) IV; him-5(e1490)V 
BR2676 srf-3(e2689) IV; him-5(e1490)V 
BR2691 srf-3(yj10) IV;  him-5(1490) V 
BR2692 daf-2(e1370) III; srf-3(e2680) IV 
BR2700 daf-2(e1370) III; srf-3(e2789) IV 
BR2705 daf-2(e1370) III; srf-3(e2689) IV 
BR2732 srf-3(e2797) IV 
BR2733 srf-3(e2797) IV; him-5(e1490) V 
BR2748 srf-3(e2797) IV;  unc-30(e191) IV 
BR2806 N2; byEx321 [pBY1565, N2 genomic DNA, pRF4] 
BR2807 N2; byEx322 [pBY1565, N2 genomic DNA, pRF4] 
BR2808 N2; byEx323 [pBY1565, N2 genomic DNA, pRF4] 
BR2809 N2; byEx324 [pBY1570, BSSKII, pRF4] 
BR2810 unc-119(ed4); byEx325 [pBY1603, BSSKII, pBY232] 
BR2811 unc-119(ed4); byEx326 [pBY1603, BSSKII, pBY232] 
BR2829 srf-3(e2789) jcls1 IV 
BR2830 srf-3(e2789) jcls1 IV; him-5(e1490) V 
BR2831 srf-3(yj10) jcls1 IV 
BR2832 srf-3(yj10) jcls1 IV; him-5(e1490) V 
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BR2841 daf-2(e1370) III; srf-3(e2797) IV 
BR2847 unc-119(ed4)III; byEx331 [pBY1605, BSSKII, pBY232] 
BR2848 unc-119(ed4)III; byEx332 [pBY1605, BSSKII, pBY232] 
BR2849 unc-119(ed4)III; byEx333 [pBY1605, BSSKII, pBY232] 
BR2871 daf-2(e1370) III; srf-3(yj10) IV 
BR2940 gly-2(qa703) I;  him-5 (e1490)V 
BR2941 gly-2(qa703) I; srf-3(e2789)IV;  him-5(e1490) V 
BR2942 gly-2(qa703)I;  srf-3(e2789)IV 
BR2995 srf-2(yj262) I; him-5(e1490) V; srf-5(ct115) X 
BR2996 srf-2(yj262) I; srf-3(e2789) IV; him-5(e1490) V 
BR2997 gly-16(qa701) I; him-5(e1490) V 
BR2999 gly-16(qa701) I;  srf-3(e2789) IV; him-5(e1490) V 
BR3000 gly-14(id48) III;  srf-3(2789) IV; him-5(e1490) V; gly-12(is47) X 
BR3001 gly-18(qa704) I;  srf-3(e2789) IV; him-5(e1490) V 
BR3016 srf-3(2789)/ dpy-20(e1282) unc-30(e191) IV; srf-4(ct109) V 
BR3031 by158 [Deletion mutant of ZK896.9] 
BR3028 srf-3(e2789) IV; him-5 (e1490) V; srf-5(ct115) X 
BR3080 srf-3(e2789) unc-30(e191)IV; byEx385 [pBY1810, BSSKII, pBY218] 
BR3081 srf-3(e2789) unc-30(e191)IV; byEx386 [pBY1810, BSSKII, pBY218] 
BR3082 srf-3(e2789) unc-30(e191)IV; byEx387 [pBY1810, BSSKII, pBY218] 
 
 
Used yeast strains 
 
Table 7: used yeast strains 
Strain Genotype Reference 
S. cerevisiae 
PRY225 
ura3-52, lys2-801am, ade2-1020c, 
his3, leu2, trp1∆1 
 
K. lactis KL3 Mat a, uraA, mnn2-2, arg-K+, pKD1+ (Guillen et al., 1998) 
 
 
 
Used E. coli strains 
Table 8: used E. coli strains 
Strain Genotype Reference 
OP50 ura- (Brenner, 1974) 
HB101 mcrB mrr hsdS20 (rB-mB-) leuB6 supE44 
ara14 galK2 lacY1 proA2 rpsL20(Smr) 
xyl-5 mtl-1 recA14 
(Boyer and Roulland-
Dussoix, 1969) 
HT115 W3110, rnc14::∆Tn10 (Takiff et al., 1989) 
DH5α recAI, endA1, gyrA96, thi, hsdR17(rK-
,mK+),relA1, supE44, ф80dlacZ∆M15, 
∆(lacZYA-argF)U169 
(Woodcock et al., 1989) 
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Constructed and used Plasmids 
 
Table 9: Plasmids 
Plasmidname Description/ Reference 
Bluescript 
SKII- 
Cloning vector (Stratagene) 
F07C6 Cosmid 
Litmus 28 Cloning vector (New England Biolabs) 
M02B1 Cosmid  
pBY1451 PstI derived subclone of M02B1 
pBY1452 BglII derived subclone of M02B1 
pBY1453 PacI derived subclone of M02B1 
pBY1454 AatII derived subclone of M02B1 
pBY1455 PstI derived subclone of M02B1 
pBY1481 PstI derived subclone of M02B1 
pBY1508 pBY1454 carrying a EcoNI deletion 
pBY1509 pBY1454 carrying a SapI deletion 
pBY1520 ZK896.9 cDNA in Bluescript 
pBY1523 ZK896.9 cDNA in pPD129.36 
pBY1554 M02B1.1::GFP 
pBY1555 M02B1.1::GFP 
pBY1564 ZK896.9::GFP  
pBY1565 ZK896.9::GFP 
pBY1570 pZK896.9::GFP 
pBY1571 pZK896.9::GFP 
pBY1601 vector containing multiple cloning site and unc-54  3’ UTR 
pBY1603 srf-3 promoter in pPD118.15 
pBY1604 partial srf-3 cDNA clone including 5’UTR 
pBY1605 GFP::M02B1.1 
pBY1606 GFP::M02B1.1 
pBY1614 ZK896.9 cDNA including 5’UTR 
pBY1618 partial srf-3 cDNA in pPD129.36 
pBY1817 srf-3 full length cDNA in Bluescript 
pBY1818 Bluescript containing srf-3 5’ and 3’ regulatory elements 
pBY1819 srf-3 cDNA fused to a VSV tag coding sequence at the 3’ end (SRF-3VSV) 
pBY1820 srf-3 cDNA fused to a VSV tag coding sequence at the 5’ end (VSVSRF-3) 
pBY1821 SRF-3VSV in pCDNA3.1- 
pBY1822 VSVSRF-3 in pG426 
pBY1824 SRF-3VSV in pG426 
pBY1825 VSVSRF-3 in pCDNA3.1- 
pBY1865 srf-3 cDNA in pBY1818 
pBY1866 SRF-3VSV in pE4 
pBY1867 VSVSRF-3 in pE4 
pBY1869 VSVSRF-3 in pBY1818 
pBY1870 SRF-3VSV in pBY1818 
pBY1907 srf-3::NLS::lacZ 
pCDNA3.1- vector for expression in mammalian cells (Invitrogene) 
pDP#MM016B unc-119 rescue injection marker (Maduro and Pilgrim, 1995) 
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pPD95.57 promoterless NLS::lac-Z vector 
(ftp://www.ciwemb.edu/pub/FireLabInfo/FireLabVectors/) 
pPD95.75 promoterless GFP vector 
(ftp://www.ciwemb.edu/pub/FireLabInfo/FireLabVectors/) 
pPD118.15 vector to tag the protein of interest with GFP at the N-terminus of the 
protein (ftp://www.ciwemb.edu/pub/FireLabInfo/FireLabVectors/) 
pPD129.36 vector for the generation of dsRNA in vitro and in vivo 
(ftp://www.ciwemb.edu/pub/FireLabInfo/FireLabVectors/) 
pE4 K. lactis expression vector (Guillen et al., 1998) 
pG426 S. cerevisiae expression vector (Mumberg et al., 1995) 
pGEM-T vector for A-overhang cloning  (Promega) 
pRF4 dominant behavioural injection marker [rol-6(su1006)]  (Mello et al., 1991) 
ZK896 Cosmid 
 
 
 
Solutions, reagents and buffers 
If not stated otherwise or amount of substance is given, all details given below are for one 
liter. If plates for growing bacteria or yeast were needed the corresponding media were 
supplemented with 2 % Agar. 
  
M9 
3 g/l KH2PO4  
6 g/l Na2HPO4 
5 g/l NaCl  
0.1 M MgSO4 
 
TBS 
137 mM NaCl 
25 mM Tris 
2.6 mM KCl 
Nystatin solution 
4 g Nystatin 
200 ml EtOH 
200 ml 7.5 M NH4Ac  
sterilize by filtrating 
NGM plates 
3 g/l NaCl 
2.5 g/l Bacto-Peptone 
17 g/l Agar 
add 967 ml H2O 
autoclave 
+ 1 ml 0.1 M CaCl2 
+ 1 ml 0.1 M MgSO4 
25 ml 1 M KH2PO4 
5 ml Nystatin solution   
1 ml Cholesterol (5 mg/ml in EtOH)  
Freezing Buffer 
5.8 g/l NaCl  
6.8 g/l KH2PO4  
30% Glycerol  
5.6 ml 1M NaOH 
add H2O to a final volume of 1 l 
autoclave  
after cooling add 1 ml of 1 M MgSO4 
   
Hypochlorite solution 
6 ml NaOCl (4%) 
2.5 ml 5 M KOH 
add H2O to a final volume of 50 ml 
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Worm lysis buffer  
50 mM KCl 
10 mM Tris pH 8.2 
2.5 mM MgCl2 
0.45% NP-40 
0.45% Tween 20 
0.01% Gelatine 
pior to use Proteinase K is added to 
a final concentration of 0.5 mg/ml 
S-Medium for liquid medium 
5.8 g NaCl 
ad 900 ml dH2O 
autoclave 
+ 50 ml KH2PO4 (1M, pH 6.0) 
+  3 ml 1 M MgSO4 
+  3 ml 1 M CaCl2 
+10 ml 1 M NaCitrat 
+ 10 ml trace metal solution  
+  1 ml Cholesterol 
+  5 ml Nystatin solution 
+  1 ml Streptomycin/PSN-Antibiotic Mixture 
 
Trace metals solution 
0.93 g Na2EDTA 
0.35 g FeSO4*7 H2O 
0.1 g MnCl2*4 H2O 
0.15 g ZnSO4*7 H2O  
0.008 g CuSO4 
add 500 ml dH2O 
sterilize  
β-galactosidase staining solution (1ml) 
614.5 µl  H2O 
250 µl  0.8 M sodium phosphate buffer  
                        pH 7.4 
  20 µl  50 mM MgCl2 
    4 µl  1% SDS 
100 µl  100 mM Redoxpuffer 
1.5 µl 50 mg/ml Kanamycin 
    2 µl  1 mg/ml DAPI 
    8 µl  5% X-Gal in Dimethylformamide 
 
Redoxbuffer 
100 mM K4 [Fe(CN)6] 
100 mM K3 [Fe(CN)6] 
LB medium 
1 % tryptone 
0.5 % yeast extract 
1 % NaCl 
sterilized by autoclaving 
 
YPD Medium 
1% Bacto Yeast extract 
2% Bacto Peptone 
2% D-(+)-Glucose 
SD-Medium 
0.67% Yeast Nitrogen Base 
2% D-(+)-Glucose    
30µg/ml Lysin 
30µg/ml Leucine 
30µg/ml Histidine 
30µg/ml Tryptophane 
30µg/ml Uracil 
 
Membrane buffer 
10 mM triethanolamine pH 7.2 
0.8 M sorbitol 
1 mM EDTA  
Transport buffer 
30 mM triethanolamine pH 7.2 
0.3 M sucrose 
5 mM MgCl2 
5 mM MnCl2 
 
2 x Spheroblast buffer 
2.8 M sorbitol 
0.1 M potassiumphosphate pH 7.5 
10 mM NaN3 
 
Stop solution 
0.5 M sucrose 
1 mM EDTA 
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TE buffer (x1) 
10 mM Tris  
1 mM EDTA pH 8.0  
autoclave 
 
TBE buffer (x1) 
90 mM Tris 
90 mM boric acid 
2.5 mM EDTA 
DNA sample buffer (10x) 
0.5 % SDS 
0.25 % Orange G 
25 % glycerol  
25 mM EDTA 
Protein sample buffer (x2) 
4 % SDS 
100 mM DTT 
150 mM Tris/HCl, pH 6.8 
0.5 % Bromphenolblau 
8 M Urea 
 
Transferbuffer 
250 mM Tris 
1.92 M glycine 
0.1 % SDS 
20% methanol 
 
Electrophorese buffer  
60 mM Tris 
0.55 % glycine 
0.1 % SDS 
Phosphate buffered saline pH 7.5 
(PBS) 
100 mM NaCl 
20  mM NaH2PO4 
80 mM Na2HPO4 
SSC (x20) 
3M NaCl 
0.3 M NaCitrate 
pH 7.0 
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Oligonucleotides  
 
Name of 
oligonucleotide
sequence 5’ → 3’ Description 
RB639 ACG TGG ATC CGG TTT AAT TAC CCA AGT TTG AG SL1 specific primer 
RB640 ACGTGGATCCGGTTTTAACCCAGTTACTCAAG SL2 specific primer 
RB744 TGT TCG AAG CCA CGT TAC AAT GGC Tc1 specific primer (L1) 
RB745 TCAAGTCAAATGGATGCTGAG Tc1 specific primer (L2) 
RB1367 TTGCTCGATTGGCCAAGTCAG Tc1 specific primer (R1) 
RB1368 ATTCACAAGCTGATCGACTCG Tc1 specific primer (R2) 
RB1476 TTT CCG AAA ATC CGG CAG ACC TGT TTC for amplification of M02B1.1 genomic region. Inner forward 
primer for nested PCR 
RB1477 GCCCGAGAGTTCGGTTAAAATACCTGTG for amplification of M02B1.1 genomic region. Outer 
forward primer for nested PCR 
RB1478 AAATGACGACGCATTTCATCCACTGC for amplification of M02B1.1 genomic region. Outmost 
forward primer for nested PCR 
RB1479 CTCAGGTCAAATCGGGTTTCCAACAGGA for amplification of M02B1.1 genomic region. Inner  reverse 
primer for nested PCR 
RB1480 GCG ACT TCT CCA CGA GGA GTA CAA AAG TTG for amplification of M02B1.1 genomic region. Outer reverse 
primer for nested PCR 
RB1481 GTGTTAGAGCTTTCCCGCTCATTCTT for amplification of M02B1.1 genomic region. Outmost 
reverse primer for nested PCR 
RB1483 TCTGTGTGTCCACGTTGCAGAGTGCAAT for deletion of ZK896.9 genomic region.  Outer forward 
primer for nested PCR 
RB1484 AAA CCA GCA GTG TGT GCT TGA GAG ACG for deletion of ZK896.9 genomic region. Inner forward 
primer for nested PCR 
RB1516 GAC TAA GCT TAT GGG GCT CAC AAA AGC AG for amplification of ZK896.9 cDNA; used for cloning 
pBY1520 
RB1517 GAC TAC GCG TTT ATG ATT TGC TGC TCT CGA C for amplification of ZK896.9 cDNA; used for cloning 
pBY1520 
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RB1518 GACTAAGCTTATGAAGACGGCAATTTTGAT for amplification of M02B1.1 cDNA; used for cloning 
pBY1817 
RB1551 CAA AAG GAA ATA TGA AGA CGG forward nested primer for amplification of M02B1.1 cDNA 
RB1552 CGAATTTTCTAGAATTTCAAACTATAAAAC reverse nested primer for amplification of M02B1.1 cDNA 
RB1553 ATT TCC AGG CCA CAA TGG GGC TC forward nested primer for amplification of ZK896.9 cDNA 
RB1554 ATTTCTAAGAGATGAAATTTATGATTTGCTGC reverse nested primer for amplification of ZK896.9 cDNA 
RB1555 CAG CAA ATC CGG ATA GAA CGC AAG CGA TGA reverse outmost primer for deletion of ZK896.9 
RB1556 CTAATGAACTCACCGAGCACCGAATTTTCTG outer reverse primer for deletion of ZK896.9 
RB1557 TTA GAC GAT GCC AGT GAC GCT GTT GTG inner reverse  primer for deletion of ZK896.9 
RB1598 GGT CTG CGC CTT TAA AGA G forward primer for sequencing of M02B1.1 genomic region 
RB1599 CTT TTC TAC GTG GCA GCT TC forward primer for sequencing of M02B1.1 genomic region 
RB1600 TGTAGTCGATGTACGGAGTC forward primer for sequencing of M02B1.1 genomic region 
RB1601 AATGACTACTGTAGCGCTGG reverse primer for sequencing of M02B1.1 genomic region 
RB1602 ACCATGAAAGTTGCGGCGTC reverse primer for sequencing of M02B1.1 genomic region 
RB1603 CGCAAAACTATGAAAAGTAGATAC reverse primer for sequencing of M02B1.1 genomic region 
RB1619 AGTTGAACGAGAGAGACTCC reverse primer for sequencing of the M02B1.1 genomic 
region and cDNA 
RB1620 TAG AGC GTG GAT GAA TCT GG reverse primer for sequencing of the M02B1.1 genomic 
region and cDNA 
RB1621 GTCAAACGTCGATGAAGTAC forward primer for sequencing of the ZK896.9 cDNA 
RB1622 TCAGCTGAAAATTCTGACGA forward primer for sequencing of the ZK896.9 cDNA 
RB1623 GTCTGGGTTACTGTAGCCAT forward primer for sequencing of the ZK896.9 cDNA 
RB1624 ACTGCAACAACGAGTCCTCC reverse primer for sequencing of the ZK896.9 cDNA 
RB1679 CAG TAA CCA TTT AGC GCG TC forward primer for sequencing of M02B1.1 genomic region 
RB1699 GAT CTC TAG ACG AAC TAT AAA ACT TTT TAA TCT C reverse primer for cloning M02B1.1 genomic region in Fire 
expression vector;used for cloning pBY1554 and pBY1555 
RB1700 GAT CGT CGA CGC TTT CCC CAA ACA TTT TTA G forward primer for cloning M02B1.1 genomic region in Fire 
expression vector; used for cloning pBY1554,  pBY1555, 
pBY1603 and 1907 
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RB1702 GAT CAC TAG TTA CTT CCT GTT GGA AAC CCG forward primer for cloning ZK896.9 genomic region in Fire 
expression vector; used for cloning pBY1564 and pBY1565 
RB1743 CGG CAA TTT TGA TAT GGT TAA forward sequencing primer for M02B1.1 genomic region 
and cDNA 
RB1744 GAT TTC AGC TAA ATT TAG CCC forward sequencing primer for M02B1.1 genomic region 
RB1745 GAC GAA TGG AGA TTC ACC AG reverse sequencing primer for M02B1.1 genomic region and 
cDNA 
RB1746 TCAAACTATAAAACTTTTTAATCTC reverse sequencing primer for M02B1.1 genomic region  
RB1762 GAT CTG GCC AGT GAT TTG CTG CTC TCG ACC A reverse primer for cloning ZK896.9 genomic region in Fire 
expression vector; used for cloning pBY1564 and pBY1565  
RB1829 GAT CCT GCA GAT GTT TGC AGA TCC GTC G anneals to a different ATG site 1.5 kb upstream of the 
predicted M02B1.1 ATG; used to determine START codon 
RB1830 GAT CGT CGA CAA GAA TTG GGA CAA CTC C reverse GFP primer anneals within the first exon of GFP 
from the fire vectors; used for cloning pBY1604 
RB1831 GAT CCT GCA GAT GTT TGT TAG TAC TGT AGC TG anneals to a different ATG site 150 bp downstream of the 
predicted M02B1.1 ATG; used to determine START codon 
RB1832 GAT CCT GCA GAT GGG TAG AAA TGA CGA CG anneals to a different ATG site 1.1 kb upstream of the 
predicted M02B1.1 ATG; used to determine START codon 
RB1849 GAT CGC TAG CGT CAT TGT GGC CTG GAA ATT reverse primer for amplification of the ZK896.9 promoter; 
used for cloning pBY1570 and pBY1571 
RB1873 GAT CGA TAT CCA TAT TTC CTT TTG ATT GTG AAG AT reverse primer for amplification of M02B1.1 promoter; used 
for cloning pBY1603 
RB1920 GAT CGC TAG CAT GAA GAC GGC AAT TTT GAT ATG for amplification of M02B1.1 to generate a N-terminal GFP 
fusion; used for cloning pBY1605  
RB1921 GAT CGA CGT CGC CTG GAA ATT GGA GGA ATT for amplification of M02B1.1 to generate a N-terminal GFP 
fusion; used for cloning pBY1605 
RB2046 GAT CTC TAG AAT TTC CTT TTG ATT GTG AAG ATT C for amplification of srf-3 promoter; used for cloning 
pBY1818 
RB2047 GAT TGT TGT ATG GTT TTG AC forward primer for sequencing of the M02B1.1 genomic 
region and cDNA 
 69
Name of 
oligonucleotide
sequence 5’ → 3’ Description 
RB2048 TAC AAG TGA GTA ATT CGG GT forward primer for sequencing of the ZK896.9 genomic 
region and cDNA 
RB2059 GAT CCT CGA GTG TGG CCT GGA AAT TGG AGG reverse primer for amplification of srf-3 3'UTR; used for 
cloning pBY1818 
RB2062 TGC GTC TCT CCA CAT ATA CTG CTC forward primer for detection of gly-2 deletion in qa703. 
RB2063 CCACTTGGTGAACTTCTTCAATG forward primer for detection of gly-2 deletion in qa703. 
RB2064 TGG ACC ATT TTC TCA ACG GAA TC forward primer annealing within the deletion of qa703.  
RB2099 TTC TTC TCG GGA TGA TGG AAT CCG reverse primer for detection of gly-1(qa703) 
RB2100 TCT AGT TTA CAC CCT GTT CGT CAG forward primer for detection of gly-1(qa703) 
RB2101 TTTC CTG GGCTCATTGAGCTTCCA forward primer for detection of gly-16(qa701) 
RB2102 TTC CTA ATC TTG CTC GAG GAG CTC reverse primer for detection of gly-16(qa701) 
RB2103 CCCGTTGTTGTGAGTGGAAGCATA forward primer for detection of gly-18(qa704) 
RB2104 CAG TGG AGA CTG AGT CTC CTG AAA reverse primer for detection of gly-18(qa704) 
RB2106 AAATTATAAAAGCAGCAGA reverse primer for reverse transcription to clone 3’ end of  
M02B1.1 
RB2107 TGA TAA TAA ATC ACA GAT TC reverse primer for reverse transcription to clone 3’ end of  
M02B1.1 
RB2108 GCATTTTTTAAGCGTCACTA reverse primer for reverse transcription to clone 3’ end of  
M02B1.1 
RB2109 GAT CAA GCT TTT ACA GAC AAA ACG CCT CTT reverse primer for amplification of srf-3 cDNA. Anneals to 
the putative Exon 6 downstream of the predicted stop; used 
for cloning pBY1817 
RB2110 GAG ATG ACA AAG GCG TGC GAA AAT forward primer for detection of by158 
RB2111 AGAGAACACAGTCCACAATCAGGC reverse (inner)  primer for detection of by158 
RB2112 CTC CTC GCG GAG AAA ATT TTG CAG reverse (outer)  primer for detection of by158 
RB2113 GTCAAGATGGCAATAAGACCGCCG forward primer for detection of gly-12 deletion.(F1) 
RB2114 GAA CAA CTA CCC AGC CAT CTC GGC forward primer for detection of gly-12 deletion.(F2) 
RB2115 CAATCACCCGTATCGTCACAGG reverse primer for detection of gly-12 deletion.(R3) 
RB2116 GAG ACA TGA CGT GGC GGT CGC  reverse primer for detection of gly-12 deletion.(R4) 
RB2117 GCGCCTTTAAAAATCGAGTACGG forward primer for detection of gly-14 deletion.(F1) 
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RB2118 CGT GCT CAT CTA CTT TTC ATG G forward primer for detection of gly-12 deletion.(F2) 
RB2119 CACCAAGAAGAATCATAACCAGG reverse primer for detection of gly-14 deletion(R3) 
RB2120 GGT ATA CGG TAG GGT ACT GTA GGG reverse primer for detection of gly-14 deletion(R4) 
RB2124 GATCTCGAGATTCTCGTCTGTATATTATAGTGACGCT forward primer for amplification of srf-3 3'UTR; used for 
cloning pBY1818 
RB2136 GAT CGA GCT CGC TTT CCC CAA ACA TTT TTA G for amplification of srf-3 promoter; used for cloning 
pBY1818 
RB2138 GAT CTC TAG ATT ACA GAC AAA ACG CCT CTT reverse primer for amplification of srf-3 cDNA; used for 
cloning pBY1820 
RB2141 GATCTCTAGAATGAAGACGGCAATTTTGAT forward primer for amplification of srf-3 cDNA; used for 
cloning pBY1819 
RB2142 GATCTCGAGATTCTCGTCTGTATATTATAGTGACGCT reverse primer for cloning M02B1.1 genomic region in Fire 
expression vector; used for cloning pBY1907 
RB2145 GAT CTC TAG AAT GTA CAC TGA TAT CGA AAT GAA CCG   
CCT GGG TAA G A T G AA  GAC GGC AAT TTT GAT 
forward primer for amplification of srf-3 cDNA; used for 
cloning pBY1820 
RB2146 GATCTCTAGATTACTTACCCAGGCGGTTCATTTCGATATCAGT
GTACAGACAAAACGCCTCTTTTG 
reverse primer for amplification of srf-3 cDNA; used for 
cloning pBY1819 
RB2180 GATCGTCGACATGAAGACGGCAATTTTGATATG forward primer for amplification of srf-3 cDNA tagged with 
a VSV-G tag at the c-terminus; used for cloning pBY1870 
RB2181 GAT CGT CGA CTT ACT TAC CCA GGC GGT T primer for amplification of srf-3 cDNA tagged with a VSV-
G tag at the c-terminus; used for cloning pBY1870 
RB2182 GATCGTCGACTTACAGACAAAACGCCTC forward primer for amplification of srf-3 cDNA tagged with 
an VSV-G tag at the n-terminus; used for cloning pBY1869 
RB2183 GAT CGT CGA CAT GTA CAC TGA TAT CGA AAT G reverse primer for amplification of srf-3 cDNA tagged with 
an VSV-G tag at the n-terminus; used for cloning 1969 
RB2218 CTCTTTGGATGAGAAATGTTC forward sequencing primer for M02B1.1 genomic region 
RB2219 GAA AGA GAT TCA AAG CTT GTG reverse sequencing primer for M02B1.1 genomic region 
RB2220 GGT CTC TCT GTT GCT GTT TG forward sequencing primer for M02B1.1 genomic region 
and cDNA 
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RB2226 GAAGATCGCGGCCGCATGAAGACGGCAATTTTGATATG for amplification of srf-3 cDNA together with RB2227; used 
for cloning pBY1873 
RB2227 GAA GAT CGC GGC CGC TTA CAG ACA AAA CGC CTC TTT TG for amplification of srf-3 cDNA together with RB2226; 
pBY1873 
RB2235 CTAAAATCCCCCGGCCGAAA forward sequencing primer for M02B1.1 genomic region 
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Abbreviations 
 
aa amino acid 
Bah biofilm absent on the head phenotype 
Bre bacillus-toxin resistant phenotype 
bp base pair 
C. briggsae Caenorhabditis briggsae 
C. elegans  Caenorhabditis elegans 
cDNA complementary (to mRNA) cDNA 
CMP cytosine-5’-monophosphate 
CMP-Sia CMP-sialic acid 
col collagen mutant 
Da Dalton 
Daf dauer larva formation abnormal phenotype 
Dar deformed anal region phenotype 
DNA desoxyribonucleic acid 
Dpy dumpy phenotype 
dsRNA double stranded RNA 
E. coli Escherichia coli 
ER endoplasmatic reticulum 
Esp enhanced susceptibility to pathogens 
phenotype 
Exc excretory canal abnormal 
FITC fluorescein-isothiocyanate 
GDP  guanosine-5’-diphosphate 
GDP-Fuc GDP-fucose 
gly glycosylation related mutant 
GFP green fluorescent protein 
GSII Griffonia simplicifolia II 
K. lactis Kluyveromyces lactis 
Lev levamisole resistance abnormal phenotype 
LPG lipophosphoglycan 
LPS lipopolysaccharide 
MDCK Madin-Darby canine kidney 
M. nematophilum Microbacterium nematophilum 
mRNA messenger RNA 
NLS nuclear localization signal 
NST nucleotide sugar transporter 
nt nucleotide 
ORF open reading frame 
PCR polymerase chain reaction 
P. aeruginosa Pseudomonas aeruginosa 
Ram ray morphology abnormal phenotype 
RNA ribonucleic acid 
RNAi  RNA mediated interference 
RT-PCR reverse transcription PCR 
S. cerevisiae Saccharomyces cerevisiae 
SDS sodium dodecyl sulphate 
SL splice leader 
Srf surface antigenicity abnormal phenotype 
Sqv squashed vulva phenotype 
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T. spiralis Trichnella spiralis 
ts temperature sensitive 
UDP uridine-5’-diphosphate 
UDP-Gal UDP-galactose 
UDP-GlcA ÛDP-glucuronic acid 
UDP-GlcNAc UDP-N-acetylglucosamine 
UDP-Glu UDP-glucose 
UDP-GalNAc UDP-N-acetylgalactosamine 
Unc uncoordinated movement phenotype 
UTR untranslated region 
VSV-G Vesicular Stomatitis Virus Glycoprotein 
WGA wheat germ agglutinin 
Y. pestis Yersinia pestis 
Y. pseudotuberculosis Yersinia pseudotuberculosis 
   
